<?xml version="1.0" encoding="UTF-8"?>
<COCHRANE_REVIEW TYPE="INTERVENTION" REVMAN_VERSION="5" ID="000000000000000000" VERSION_NO="2.0" STAGE="R" STATUS="A">
<COVER_SHEET>
<TITLE>Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis [Data only. When citing this record quote "Cochrane Database of Systematic Reviews 2014, Issue 12".]</TITLE>
<CONTACT>
<PERSON ID="19787" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Suetonia</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Palmer</LAST_NAME>
<SUFFIX>MBChB</SUFFIX>
<EMAIL_1>suetonia.palmer@otago.ac.nz</EMAIL_1>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>University of Otago Christchurch</ORGANISATION>
<ADDRESS_1>2 Riccarton Ave</ADDRESS_1>
<ADDRESS_2>PO Box 4345</ADDRESS_2>
<CITY>Christchurch</CITY>
<ZIP>8140</ZIP>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<PHONE_1>+64 21626008</PHONE_1>
<FAX_1>+64 3 3253368</FAX_1>
</ADDRESS>
</PERSON>
</CONTACT>
<CREATORS>
<PERSON ID="19787" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Suetonia</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Palmer</LAST_NAME>
<SUFFIX>MBChB</SUFFIX>
<EMAIL_1>suetonia.palmer@otago.ac.nz</EMAIL_1>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>University of Otago Christchurch</ORGANISATION>
<ADDRESS_1>2 Riccarton Ave</ADDRESS_1>
<ADDRESS_2>PO Box 4345</ADDRESS_2>
<CITY>Christchurch</CITY>
<ZIP>8140</ZIP>
<COUNTRY CODE="NZ">New Zealand</COUNTRY>
<PHONE_1>+64 21626008</PHONE_1>
<FAX_1>+64 3 3253368</FAX_1>
</ADDRESS>
</PERSON>
<PERSON ID="44611609938785056425091220225141" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Valeria</FIRST_NAME>
<LAST_NAME>Saglimbene</LAST_NAME>
<SUFFIX>MSc Pham Chem</SUFFIX>
<EMAIL_1>saglimbene@negrisud.it</EMAIL_1>
<EMAIL_2>leava@hotmail.it</EMAIL_2>
<ADDRESS>
<DEPARTMENT>Clinical Pharmacology and Epidemiology</DEPARTMENT>
<ORGANISATION>Mario Negri Sud Consortium</ORGANISATION>
<ADDRESS_1>Via Nazionale 8/A</ADDRESS_1>
<CITY>Santa Maria Imbaro</CITY>
<ZIP>66030</ZIP>
<REGION>Chieti</REGION>
<COUNTRY CODE="IT">Italy</COUNTRY>
</ADDRESS>
</PERSON>
<PERSON ID="74037955184144047115110107132942" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Dimitris</FIRST_NAME>
<LAST_NAME>Mavridis</LAST_NAME>
<POSITION>Post-doctoral Research Statistician</POSITION>
<EMAIL_1>dimi.mavridis@gmail.com</EMAIL_1>
<ADDRESS>
<DEPARTMENT>Department of Hygiene and Epidemiology, School of Medicine</DEPARTMENT>
<ORGANISATION>University of Ioannina</ORGANISATION>
<ADDRESS_1>Panepistimioupoli</ADDRESS_1>
<CITY>Ioannina</CITY>
<ZIP>45110</ZIP>
<COUNTRY CODE="GR">Greece</COUNTRY>
<PHONE_1>+302651007836</PHONE_1>
<PHONE_2>+306942673223</PHONE_2>
</ADDRESS>
</PERSON>
<PERSON ID="17174" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Georgia</FIRST_NAME>
<LAST_NAME>Salanti</LAST_NAME>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>georgia.salanti@googlemail.com</EMAIL_1>
<MOBILE_PHONE>+30 6971863717</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Hygiene and Epidemiology</DEPARTMENT>
<ORGANISATION>University of Ioannina School of Medicine</ORGANISATION>
<ADDRESS_1>Medical School Campus</ADDRESS_1>
<ADDRESS_2>University of Ioannina</ADDRESS_2>
<CITY>Ioannina</CITY>
<ZIP>45110</ZIP>
<COUNTRY CODE="GR">Greece</COUNTRY>
<PHONE_1>+30 26510 07757</PHONE_1>
<FAX_1>+30 26510 07853</FAX_1>
</ADDRESS>
</PERSON>
<PERSON ID="4552" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Jonathan</FIRST_NAME>
<MIDDLE_INITIALS>C</MIDDLE_INITIALS>
<LAST_NAME>Craig</LAST_NAME>
<EMAIL_1>jonathan.craig@sydney.edu.au</EMAIL_1>
<EMAIL_2>JonC@health.usyd.edu.au</EMAIL_2>
<ADDRESS>
<DEPARTMENT>Sydney School of Public Health</DEPARTMENT>
<ORGANISATION>The University of Sydney</ORGANISATION>
<ADDRESS_1>Edward Ford Building A27</ADDRESS_1>
<CITY>Sydney</CITY>
<ZIP>2006</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
</ADDRESS>
</PERSON>
<PERSON ID="3743FFC282E26AA200DAFFB9ACA5939B" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Marcello</FIRST_NAME>
<LAST_NAME>Tonelli</LAST_NAME>
<POSITION>Associate Vice President (Health Research)</POSITION>
<EMAIL_1>mtonelli@ualberta.ca</EMAIL_1>
<EMAIL_2>mtonelli-admin@med.ualberta.ca</EMAIL_2>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>University of Calgary</ORGANISATION>
<ADDRESS_1>7th Floor, TRW Building</ADDRESS_1>
<ADDRESS_2>3280 Hospital Drive NW</ADDRESS_2>
<CITY>Calgary</CITY>
<ZIP>T2N 4Z6</ZIP>
<REGION>AB</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+14032106930</PHONE_1>
<FAX_1>+14032701828</FAX_1>
</ADDRESS>
</PERSON>
<PERSON ID="12360" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Natasha</FIRST_NAME>
<LAST_NAME>Wiebe</LAST_NAME>
<POSITION>Research Associate</POSITION>
<EMAIL_1>nwiebe@ualberta.ca</EMAIL_1>
<URL>www.ualberta.ca/~nwiebe</URL>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>University of Alberta</ORGANISATION>
<ADDRESS_1>3048 RTF</ADDRESS_1>
<ADDRESS_2>8308-114 Street NW</ADDRESS_2>
<CITY>Edmonton</CITY>
<ZIP>T6G 2V2</ZIP>
<REGION>AB</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 780 407 1532</PHONE_1>
<FAX_1>+1 780 407 7864</FAX_1>
</ADDRESS>
</PERSON>
<PERSON ID="16154" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Giovanni</FIRST_NAME>
<MIDDLE_INITIALS>FM</MIDDLE_INITIALS>
<LAST_NAME>Strippoli</LAST_NAME>
<POSITION>Editor and Regional Coordinator</POSITION>
<EMAIL_1>strippoli@negrisud.it</EMAIL_1>
<EMAIL_2>gfmstrippoli@gmail.com</EMAIL_2>
<ADDRESS>
<DEPARTMENT>Cochrane Renal Group, Centre for Kidney Research</DEPARTMENT>
<ORGANISATION>The Children's Hospital at Westmead</ORGANISATION>
<ADDRESS_1>Locked Bag 4001</ADDRESS_1>
<CITY>Westmead</CITY>
<ZIP>2145</ZIP>
<REGION>NSW</REGION>
<COUNTRY CODE="AU">Australia</COUNTRY>
<PHONE_1>+39 080 5580776</PHONE_1>
<PHONE_2>+39 349 5705884</PHONE_2>
<FAX_1>+39 080 5580776</FAX_1>
</ADDRESS>
</PERSON>
</CREATORS>
<DATES>
<UP_TO_DATE>
<DATE DAY="" MONTH="" YEAR="" />
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="" MONTH="" YEAR="" />
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR="" />
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR="" />
<REVIEW_PUBLISHED ISSUE="" YEAR="" />
<LAST_CITATION_ISSUE ISSUE="" YEAR="" />
</DATES>
<WHATS_NEW />
<HISTORY />
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES />
<EXTERNAL_SOURCES />
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO" />
<KEYWORDS />
</COVER_SHEET>
<MAIN_TEXT>
<SUMMARY>
<TITLE>The relative safety and effectiveness of different epoetin drugs for treating anaemia in people with chronic kidney disease</TITLE>
<SUMMARY_BODY>
<P>Several drugs are available to treat anaemia for people who have kidney disease but whether these drugs are similar or different in their ability to improve symptoms of anaemia, such as tiredness and breathlessness, and whether they are equally safe based on their risks of causing a stroke or a heart attack, is not clear. This is because research studies that compare the effects of one drug directly with another are not common. We have found 56 studies that measure the safety and how these drugs help to improve how patients who have kidney disease feel, function and survive that have involved 15,596 people. Our last search of the literature was in February 2014.</P>
<P>We are somewhat confident that four of the drugs (epoetin alfa, epoetin beta, darbepoetin beta and methoxy polyethylene glycol-epoetin beta) are better than a placebo injection to prevent patients needing to have a blood transfusion. We are less certain that biosimilar drugs are better than placebo to help patients avoid a blood transfusion.</P>
<P>All erythropoiesis-stimulating agents cause high blood pressure, but we cannot be very sure if biosimilar products have effects on blood pressure. We cannot be confident in the other important effects of these drugs - we are not sure whether the drugs are similar or different in their effects on the chances of death, a heart attack or stroke; the risk of having a clot in a fistula or vascular catheter needed for dialysis; or the chances of needing dialysis for people who have milder kidney disease. We are unsure whether the different drugs are better at improving symptoms such as tiredness or breathlessness than others as the available research studies generally do not measure these aspects of treatment very well.</P>
<P>Overall, whether different drugs are safer or better at treating symptoms of anaemia for people with kidney disease is poorly known. It is likely that most if not all the drugs prevent the need for a patient to require a blood transfusion. The choice of which drug to use to treat anaemia when a patient has kidney disease can be decided between patients and health professionals based on shared preferences for how frequently the drug is given and considering drug costs and availability.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P />
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P />
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P />
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P />
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P />
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P />
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P />
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY>
<BACKGROUND>
<P />
<CONDITION>
<P />
</CONDITION>
<INTERVENTION>
<P />
</INTERVENTION>
<THEORY>
<P />
</THEORY>
<IMPORTANCE>
<P />
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P />
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P />
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P />
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P />
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P />
<CRIT_OUTCOMES_PRIMARY>
<P />
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY>
<P />
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P />
<ELECTRONIC_SEARCHES>
<P />
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES>
<P />
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P />
<STUDY_SELECTION>
<P />
</STUDY_SELECTION>
<DATA_EXTRACTION>
<P />
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT>
<P />
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES>
<P />
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS>
<P />
</UNIT_OF_ANALYSIS>
<MISSING_DATA>
<P />
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT>
<P />
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT>
<P />
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS>
<P />
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS>
<P />
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS>
<P />
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P />
<SEARCH_RESULTS>
<P />
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR>
<P />
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR>
<P />
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P />
<ALLOCATION>
<P />
</ALLOCATION>
<BLINDING>
<P />
</BLINDING>
<EXCLUSIONS>
<P />
</EXCLUSIONS>
<SELECTIVE_REPORTING>
<P />
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES>
<P />
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P />
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P />
<SUMMARY_OF_RESULTS>
<P />
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS>
<P />
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE>
<P />
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES>
<P />
</POTENTIAL_BIASES>
<AGREEMENT>
<P />
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P />
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P />
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P />
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P />
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P />
</CONTRIBUTIONS>
<PRO_REV_DIFF>
<P />
</PRO_REV_DIFF>
<PUBLIC_NOTES>
<P />
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Akiba-2010" NAME="Akiba 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akizawa-2011" NAME="Akizawa 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alexander-2007" NAME="Alexander 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Allon-2002" NAME="Allon 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-AMICUS-Study-2007" NAME="AMICUS Study 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arabul-2009" NAME="Arabul 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-ARCTOS-Study-2008" NAME="ARCTOS Study 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bahlmann-1991" NAME="Bahlmann 1991" YEAR="1991">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bennett-1991" NAME="Bennett 1991" YEAR="1991">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1995" NAME="Brown 1995" YEAR="1995">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canadian-EPO-Study-1990" NAME="Canadian EPO Study 1990" YEAR="1990">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008" NAME="Chen 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2012e" NAME="Chen 2012e" YEAR="2012 Jul">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clyne-1992" NAME="Clyne 1992" YEAR="1992">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-CORDATUS-Study-2011" NAME="CORDATUS Study 2011" YEAR="2011">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coyne-2000" NAME="Coyne 2000" YEAR="2000">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coyne-2006a" NAME="Coyne 2006a" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-EPOCARES-Study-2010" NAME="EPOCARES Study 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gertz-2010" NAME="Gertz 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goh-2007" NAME="Goh 2007" YEAR="2007 Oct">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haag_x002d_Weber-2009" NAME="Haag-Weber 2009" YEAR="2009">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haag_x002d_Weber-2012" NAME="Haag-Weber 2012" YEAR="">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirakata-2010" NAME="Hirakata 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hori-2004" NAME="Hori 2004" YEAR="2004">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kleinman-1989" NAME="Kleinman 1989" YEAR="1989">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klinkmann-1992" NAME="Klinkmann 1992" YEAR="1993">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krivoshiev-2008" NAME="Krivoshiev 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krivoshiev-2010" NAME="Krivoshiev 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuriyama-1997" NAME="Kuriyama 1997" YEAR="1997">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008d" NAME="Li 2008d" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Locatelli-2001" NAME="Locatelli 2001" YEAR="2001">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-2007" NAME="Martin 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MAXIMA-Study-2007" NAME="MAXIMA Study 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milutinovic-2006" NAME="Milutinovic 2006" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nissenson-1995" NAME="Nissenson 1995" YEAR="1995">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nissenson-2002" NAME="Nissenson 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Palazzuoli-2007" NAME="Palazzuoli 2007" YEAR="2007 Oct">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2012" NAME="Patel 2012" YEAR="2012">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-PATRONUS-Study-2010" NAME="PATRONUS Study 2010" YEAR="2010">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-PROTOS-Study-2007" NAME="PROTOS Study 2007" YEAR="2007">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roth-1994" NAME="Roth 1994" YEAR="1994">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RUBRA-Study-2008" NAME="RUBRA Study 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaheen-1993" NAME="Shaheen 1993" YEAR="1993">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shand-1993" NAME="Shand 1993" YEAR="1993">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sikole-1993" NAME="Sikole 1993" YEAR="1993">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2007" NAME="Smith 2007" YEAR="2006">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spinowitz-2006" NAME="Spinowitz 2006" YEAR="2006 Dec">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-STRIATA-Study-2008" NAME="STRIATA Study 2008" YEAR="2008">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teehan-1989" NAME="Teehan 1989" YEAR="1989">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TIVOLI-Study-2013" NAME="TIVOLI Study 2013" YEAR="2013">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tolman-2005" NAME="Tolman 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-TREAT-Study-2005" NAME="TREAT Study 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Biesen-2005" NAME="Van Biesen 2005" YEAR="2005">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Loo-1996" NAME="Van Loo 1996" YEAR="1996">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanrenterghem-2002" NAME="Vanrenterghem 2002" YEAR="2002">
<IDENTIFIERS />
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watson-1990" NAME="Watson 1990" YEAR="1990">
<IDENTIFIERS />
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES />
<AWAITING_STUDIES />
<ONGOING_STUDIES />
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES />
<OTHER_VERSIONS_REFERENCES />
<PENDING_REFERENCES />
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Akiba-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Akizawa-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Alexander-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Allon-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-AMICUS-Study-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Arabul-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-ARCTOS-Study-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bahlmann-1991">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bennett-1991">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brown-1995">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Canadian-EPO-Study-1990">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chen-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chen-2012e">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Clyne-1992">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-CORDATUS-Study-2011">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Coyne-2000">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Coyne-2006a">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-EPOCARES-Study-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gertz-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Goh-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Haag_x002d_Weber-2009">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Haag_x002d_Weber-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hirakata-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hori-2004">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kleinman-1989">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Klinkmann-1992">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Krivoshiev-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Krivoshiev-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kuriyama-1997">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Li-2008d">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Locatelli-2001">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Martin-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-MAXIMA-Study-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Milutinovic-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Nissenson-1995">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Nissenson-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Palazzuoli-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Patel-2012">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-PATRONUS-Study-2010">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-PROTOS-Study-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Roth-1994">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-RUBRA-Study-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shaheen-1993">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shand-1993">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sikole-1993">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Smith-2007">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Spinowitz-2006">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-STRIATA-Study-2008">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Teehan-1989">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TIVOLI-Study-2013">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tolman-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-TREAT-Study-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Van-Biesen-2005">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Van-Loo-1996">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vanrenterghem-2002">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Watson-1990">
<CHAR_METHODS><P /></CHAR_METHODS>
<CHAR_PARTICIPANTS><P /></CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS><P /></CHAR_INTERVENTIONS>
<CHAR_OUTCOMES><P /></CHAR_OUTCOMES>
<CHAR_NOTES><P /></CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P />
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS />
<SOF_TABLES />
<ADDITIONAL_TABLES />
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>ESA versus ESA or placebo/no treatment</NAME>
<DICH_OUTCOME CHI2="79.61218282761651" CI_END="0.6819545414184562" CI_START="0.5140294681073924" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5920681803633342" ESTIMABLE="YES" EVENTS_1="425" EVENTS_2="708" I2="77.39039508692379" I2_Q="83.36603720949434" ID="CMP-001.01" LOG_CI_END="-0.16624457412521051" LOG_CI_START="-0.2890119832039643" LOG_EFFECT_SIZE="-0.22762827866458749" METHOD="MH" NO="1" P_CHI2="1.001769889263926E-9" P_Q="9.47751584989831E-8" P_Z="3.645645828602419E-13" Q="48.09437234383046" RANDOM="YES" SCALE="1000.0" SORT_BY="WEIGHT" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.6205532620092804" TOTALS="SUB" TOTAL_1="4301" TOTAL_2="4746" WEIGHT="900.0" Z="7.268105295913561">
<NAME>Blood transfusion</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.52800397235793" CI_END="0.8374246786471793" CI_START="0.00628410212949221" DF="2" EFFECT_SIZE="0.07254283015140828" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="35" I2="81.00304668148729" ID="CMP-001.01.01" LOG_CI_END="-0.0770542447316714" LOG_CI_START="-2.201756765402516" LOG_EFFECT_SIZE="-1.1394055050670937" NO="1" P_CHI2="0.005174564680495597" P_Z="0.0355424419893493" STUDIES="3" TAU2="3.608754100903143" TOTAL_1="117" TOTAL_2="79" WEIGHT="100.0" Z="2.102123692132746">
<NAME>Epoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="2.0721662549647943" CI_START="0.0035455353825530876" EFFECT_SIZE="0.08571428571428572" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.31642459697917297" LOG_CI_START="-2.4503181762403994" LOG_EFFECT_SIZE="-1.0669467896306133" ORDER="2" O_E="0.0" SE="1.625198400586784" STUDY_ID="STD-Kleinman-1989" TOTAL_1="7" TOTAL_2="7" VAR="2.641269841269841" WEIGHT="24.9223958214622" />
<DICH_DATA CI_END="0.05989027097340801" CI_START="0.002420507021698821" EFFECT_SIZE="0.012040133779264214" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="23" LOG_CI_END="-1.2226437219468547" LOG_CI_START="-2.61609365316743" LOG_EFFECT_SIZE="-1.9193686875571423" ORDER="1" O_E="0.0" SE="0.8185193872873701" STUDY_ID="STD-Canadian-EPO-Study-1990" TOTAL_1="67" TOTAL_2="32" VAR="0.6699739873652917" WEIGHT="36.40464347513322" />
<DICH_DATA CI_END="1.2563360352344684" CI_START="0.09933980900336647" EFFECT_SIZE="0.35327635327635326" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.09910581673325251" LOG_CI_START="-1.0028766793404305" LOG_EFFECT_SIZE="-0.45188543130358905" ORDER="3" O_E="0.0" SE="0.6473099730950125" STUDY_ID="STD-Roth-1994" TOTAL_1="43" TOTAL_2="40" VAR="0.4190102012682658" WEIGHT="38.67296070340458" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.21280448117473144" CI_END="0.2051640013828233" CI_START="0.02579954106622427" DF="1" EFFECT_SIZE="0.07275394888930115" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="29" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.6878988393316994" LOG_CI_START="-1.588388019392548" LOG_EFFECT_SIZE="-1.1381434293621238" NO="2" P_CHI2="0.6445781187727782" P_Z="7.253034188597945E-7" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="87" WEIGHT="100.0" Z="4.954462930115238">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="3.7408952330572918" CI_START="0.005948326970254736" EFFECT_SIZE="0.14917127071823205" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5729755455833355" LOG_CI_START="-2.2256051670037302" LOG_EFFECT_SIZE="-0.8263148107101972" ORDER="9" O_E="0.0" SE="1.643900163771591" STUDY_ID="STD-Bennett-1991" TOTAL_1="90" TOTAL_2="41" VAR="2.7024077484482643" WEIGHT="10.353360215634853" />
<DICH_DATA CI_END="0.20015993663715254" CI_START="0.022403162373864152" EFFECT_SIZE="0.06696428571428571" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="28" LOG_CI_END="-0.6986228451313675" LOG_CI_START="-1.6496906734255958" LOG_EFFECT_SIZE="-1.1741567592784816" ORDER="8" O_E="0.0" SE="0.5586619502017071" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="53" TOTAL_2="46" VAR="0.3121031746031746" WEIGHT="89.64663978436515" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6265529246865277" CI_START="0.455455967791104" DF="0" EFFECT_SIZE="0.5341977804946864" ESTIMABLE="YES" EVENTS_1="297" EVENTS_2="496" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="-0.2030422384311636" LOG_CI_START="-0.34155360303718757" LOG_EFFECT_SIZE="-0.2722979207341756" NO="3" P_CHI2="1.0" P_Z="1.2967839589726155E-14" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="7.706141936037441">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="0.6265529246865276" CI_START="0.455455967791104" EFFECT_SIZE="0.5341977804946864" ESTIMABLE="YES" EVENTS_1="297" EVENTS_2="496" LOG_CI_END="-0.20304223843116367" LOG_CI_START="-0.34155360303718757" LOG_EFFECT_SIZE="-0.2722979207341756" ORDER="5" O_E="0.0" SE="0.08136226121189115" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.006619817549512008" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="58.967791029188156" CI_START="0.16347576473004405" DF="0" EFFECT_SIZE="3.1048034934497815" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-001.01.04" LOG_CI_END="1.770614859136076" LOG_CI_START="-0.7865466223563194" LOG_EFFECT_SIZE="0.49203411838987826" NO="4" P_CHI2="1.0" P_Z="0.45069930041814377" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="100.0" Z="0.7542497086623244">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="58.967791029188156" CI_START="0.16347576473004405" EFFECT_SIZE="3.1048034934497815" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.770614859136076" LOG_CI_START="-0.7865466223563194" LOG_EFFECT_SIZE="0.49203411838987826" ORDER="6" O_E="0.0" SE="1.5020893123821144" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="2.2562723023725733" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.181059769010423" CI_START="0.05616535674103967" DF="0" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-001.01.05" LOG_CI_END="0.3386675669981176" LOG_CI_START="-1.2505314782975663" LOG_EFFECT_SIZE="-0.4559319556497244" NO="5" P_CHI2="1.0" P_Z="0.26075667711391837" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="18" WEIGHT="100.0" Z="1.124604517124045">
<NAME>Epoetin beta versus no control</NAME>
<DICH_DATA CI_END="2.181059769010423" CI_START="0.05616535674103967" EFFECT_SIZE="0.35" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3386675669981176" LOG_CI_START="-1.2505314782975663" LOG_EFFECT_SIZE="-0.4559319556497244" ORDER="4" O_E="0.0" SE="0.933503385868831" STUDY_ID="STD-Van-Biesen-2005" TOTAL_1="22" TOTAL_2="18" VAR="0.8714285714285714" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6354610419314257" CI_END="3.9656018580939776" CI_START="1.3424849696676948" DF="2" EFFECT_SIZE="2.307327651240163" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="24" I2="0.0" ID="CMP-001.01.06" LOG_CI_END="0.5983091093870512" LOG_CI_START="0.12790943207965852" LOG_EFFECT_SIZE="0.36310927073335486" NO="6" P_CHI2="0.4414325564406295" P_Z="0.002479294766599469" STUDIES="3" TAU2="0.0" TOTAL_1="532" TOTAL_2="659" WEIGHT="100.00000000000001" Z="3.025857063353878">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="8.243828299192785" CI_START="0.013478096228907492" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.916128937802753" LOG_CI_START="-1.8703714472420776" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="10" O_E="0.0" SE="1.6368041195746965" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="2.6791277258566972" WEIGHT="2.8498094054979184" />
<DICH_DATA CI_END="7.611560825577399" CI_START="0.42985172627920726" EFFECT_SIZE="1.8088235294117647" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.8814737222672878" LOG_CI_START="-0.3666813248009646" LOG_EFFECT_SIZE="0.2573961987331616" ORDER="11" O_E="0.0" SE="0.7331724531150194" STUDY_ID="STD-Locatelli-2001" TOTAL_1="37" TOTAL_2="129" VAR="0.5375418460066954" WEIGHT="14.203551683270376" />
<DICH_DATA CI_END="4.659374219488044" CI_START="1.4185048067911241" EFFECT_SIZE="2.5708645874457163" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="17" LOG_CI_END="0.668327592382545" LOG_CI_START="0.15183081179864857" LOG_EFFECT_SIZE="0.41007920209059684" ORDER="12" O_E="0.0" SE="0.3033927656152786" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="369" VAR="0.0920471702276874" WEIGHT="82.94663891123172" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7001577418409659" CI_END="1.220309678287825" CI_START="0.4225233784409776" DF="2" EFFECT_SIZE="0.7180594460171068" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="59" I2="0.0" ID="CMP-001.01.07" LOG_CI_END="0.0864700556789649" LOG_CI_START="-0.3741492563071458" LOG_EFFECT_SIZE="-0.14383960031409046" NO="7" P_CHI2="0.7046326067070376" P_Z="0.22091717196073068" STUDIES="3" TAU2="0.0" TOTAL_1="726" TOTAL_2="1097" WEIGHT="100.0" Z="1.2240929931950157">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="3.2283114024995654" CI_START="0.03441771788963163" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5089754200600598" LOG_CI_START="-1.4632179294993848" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="14" O_E="0.0" SE="1.1584761360457458" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="1.3420669577874815" WEIGHT="5.454881299934314" />
<DICH_DATA CI_END="2.2468440716897855" CI_START="0.3605056577828397" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.35157293394362976" LOG_CI_START="-0.44308791506498" LOG_EFFECT_SIZE="-0.045757490560675115" ORDER="13" O_E="0.0" SE="0.4667877163423008" STUDY_ID="STD-Krivoshiev-2008" TOTAL_1="304" TOTAL_2="305" VAR="0.21789077212806027" WEIGHT="33.59855894673697" />
<DICH_DATA CI_END="1.339460615698558" CI_START="0.3442776633343104" EFFECT_SIZE="0.6790775882776844" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="46" LOG_CI_END="0.1269299485256025" LOG_CI_START="-0.463091153320118" LOG_EFFECT_SIZE="-0.1680806023972578" ORDER="15" O_E="0.0" SE="0.34658131587573404" STUDY_ID="STD-Martin-2007" TOTAL_1="192" TOTAL_2="560" VAR="0.12011860851415535" WEIGHT="60.94655975332871" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.1513729105695" CI_START="0.16641280867533262" DF="0" EFFECT_SIZE="0.8311688311688312" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-001.01.08" LOG_CI_END="0.618191747044716" LOG_CI_START="-0.7788132494219054" LOG_EFFECT_SIZE="-0.08031075118859467" NO="8" P_CHI2="1.0" P_Z="0.8217085180153338" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="135" WEIGHT="100.00000000000001" Z="0.22534805573225997">
<NAME>Epoetin beta versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="4.1513729105695" CI_START="0.16641280867533262" EFFECT_SIZE="0.8311688311688312" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.618191747044716" LOG_CI_START="-0.7788132494219054" LOG_EFFECT_SIZE="-0.08031075118859467" ORDER="16" O_E="0.0" SE="0.8206076502107542" STUDY_ID="STD-AMICUS-Study-2007" TOTAL_1="46" TOTAL_2="135" VAR="0.6733969155844155" WEIGHT="100.00000000000001" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.348951052056079" CI_END="1.9462273222844615" CI_START="0.4506818889452472" DF="3" EFFECT_SIZE="0.9365518703862652" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="54" I2="43.914237187741094" ID="CMP-001.01.09" LOG_CI_END="0.2891935651450398" LOG_CI_START="-0.346129894090505" LOG_EFFECT_SIZE="-0.028468164472732548" NO="9" P_CHI2="0.14795744956811385" P_Z="0.8605706642209823" STUDIES="4" TAU2="0.23472137711621632" TOTAL_1="585" TOTAL_2="606" WEIGHT="100.00000000000001" Z="0.17564777834476933">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="15.14308925933011" CI_START="0.023360677867636577" EFFECT_SIZE="0.5947712418300654" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.1802144822591492" LOG_CI_START="-1.6315145592521596" LOG_EFFECT_SIZE="-0.2256500384965052" ORDER="20" O_E="0.0" SE="1.6516235572669693" STUDY_ID="STD-TIVOLI-Study-2013" TOTAL_1="25" TOTAL_2="46" VAR="2.727860374919198" WEIGHT="4.701047553780918" />
<DICH_DATA CI_END="9.233369816224444" CI_START="0.8967377169566076" EFFECT_SIZE="2.877483443708609" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.9653602303325469" LOG_CI_START="-0.04733456334951508" LOG_EFFECT_SIZE="0.45901283349151584" ORDER="17" O_E="0.0" SE="0.5948619347289192" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="162" VAR="0.3538607213894329" WEIGHT="23.66235353341858" />
<DICH_DATA CI_END="1.4383745412317146" CI_START="0.16009123657014745" EFFECT_SIZE="0.4798657718120805" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.15787198758407084" LOG_CI_START="-0.7956324408064577" LOG_EFFECT_SIZE="-0.3188802266111935" ORDER="18" O_E="0.0" SE="0.5600932211596389" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="154" TOTAL_2="153" VAR="0.31370441638898017" WEIGHT="25.394935583295293" />
<DICH_DATA CI_END="1.3214752202875064" CI_START="0.48103251995398455" EFFECT_SIZE="0.7972907595549105" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="39" LOG_CI_END="0.12105902384813196" LOG_CI_START="-0.3178255623805145" LOG_EFFECT_SIZE="-0.09838326926619129" ORDER="19" O_E="0.0" SE="0.25780297846444666" STUDY_ID="STD-PATRONUS-Study-2010" TOTAL_1="244" TOTAL_2="245" VAR="0.06646237570513995" WEIGHT="46.241663329505215" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.2421572597832986" CI_END="1.4759264351895696" CI_START="0.5522229626508849" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9027959175224174" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="38" I2="0.0" I2_Q="6.178097937467651" ID="CMP-001.02" LOG_CI_END="0.16906471142507626" LOG_CI_START="-0.25788553839717954" LOG_EFFECT_SIZE="-0.044410413486051604" METHOD="IV" NO="2" P_CHI2="0.5373648242349568" P_Q="0.30188529459578284" P_Z="0.6834629742630922" Q="1.0658492079317465" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="442" TOTAL_2="288" WEIGHT="200.0" Z="0.4077421714002039">
<NAME>Fatigue</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.1763080518515522" CI_END="1.5497079393875672" CI_START="0.5723302606971686" DF="1" EFFECT_SIZE="0.9417774413066806" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="36" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.19024985800004549" LOG_CI_START="-0.24235329112399914" LOG_EFFECT_SIZE="-0.02605171656197686" NO="1" P_CHI2="0.6745654358791684" P_Z="0.8133851204678031" STUDIES="2" TAU2="0.0" TOTAL_1="350" TOTAL_2="201" WEIGHT="100.00000000000001" Z="0.2360612783347039">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="2.6403488649596216" CI_START="0.20225496551843725" EFFECT_SIZE="0.7307692307692307" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="0.42166131327780837" LOG_CI_START="-0.6941008073137864" LOG_EFFECT_SIZE="-0.13621974701798903" ORDER="121" O_E="0.0" SE="0.6554041927470753" STUDY_ID="STD-Allon-2002" TOTAL_1="15" TOTAL_2="32" VAR="0.4295546558704454" WEIGHT="15.032670091300927" />
<DICH_DATA CI_END="1.6908171088109438" CI_START="0.5738289272189234" EFFECT_SIZE="0.9850074962518741" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="23" LOG_CI_END="0.22809663365934257" LOG_CI_START="-0.241217562372879" LOG_EFFECT_SIZE="-0.006560464356768167" ORDER="124" O_E="0.0" SE="0.2756774818920645" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="169" VAR="0.07599807402234955" WEIGHT="84.96732990869909" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.035239210086212E-32" CI_END="3.905699693536002" CI_START="0.008750037366688728" DF="0" EFFECT_SIZE="0.18486486486486484" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="100.0" ID="CMP-001.02.02" LOG_CI_END="0.5916988476425495" LOG_CI_START="-2.0579900923363073" LOG_EFFECT_SIZE="-0.7331456223468789" NO="2" P_CHI2="0.0" P_Z="0.27809462318346645" STUDIES="1" TAU2="0.0" TOTAL_1="92" TOTAL_2="87" WEIGHT="100.0" Z="1.0846095883500595">
<NAME>Epoetin alfa v biosimilar ESA</NAME>
<DICH_DATA CI_END="3.905699693536003" CI_START="0.008750037366688728" EFFECT_SIZE="0.18486486486486486" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5916988476425497" LOG_CI_START="-2.0579900923363073" LOG_EFFECT_SIZE="-0.7331456223468787" ORDER="131" O_E="0.0" SE="1.5564403995153682" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.422506717243559" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7412424469020342" CI_END="0.9962959123203838" CI_START="0.49094478194039637" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6993756354222236" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="98" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.0016116515351520713" LOG_CI_START="-0.3089673515575594" LOG_EFFECT_SIZE="-0.15528950154635576" METHOD="IV" NO="3" P_CHI2="0.6903055014438613" P_Q="0.9054089047090944" P_Z="0.04764529285246649" Q="0.014120910370094596" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="591" TOTAL_2="707" WEIGHT="200.0" Z="1.980518533971195">
<NAME>Breathlessness</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0978820432663534" CI_START="0.459450796212033" DF="0" EFFECT_SIZE="0.7102272727272727" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="44" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.04055568190787992" LOG_CI_START="-0.33776099152006683" LOG_EFFECT_SIZE="-0.14860265480609341" NO="1" P_CHI2="1.0" P_Z="0.12362220312357339" STUDIES="1" TAU2="0.0" TOTAL_1="335" TOTAL_2="169" WEIGHT="100.0" Z="1.5397463124630322">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="1.0978820432663534" CI_START="0.459450796212033" EFFECT_SIZE="0.7102272727272727" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="44" LOG_CI_END="0.04055568190787992" LOG_CI_START="-0.33776099152006683" LOG_EFFECT_SIZE="-0.14860265480609341" ORDER="125" O_E="0.0" SE="0.22222508666931187" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="169" VAR="0.049383989145183174" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7271215365319398" CI_END="1.2453726997155992" CI_START="0.36996112874552955" DF="1" EFFECT_SIZE="0.6787779384273258" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="54" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.09529934115668147" LOG_CI_START="-0.43184390419827706" LOG_EFFECT_SIZE="-0.1682722815207978" NO="2" P_CHI2="0.3938178308470519" P_Z="0.21082446110110842" STUDIES="2" TAU2="0.0" TOTAL_1="256" TOTAL_2="538" WEIGHT="100.0" Z="1.2513016690750478">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="3.905699693536003" CI_START="0.008750037366688728" EFFECT_SIZE="0.18486486486486486" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5916988476425497" LOG_CI_START="-2.0579900923363073" LOG_EFFECT_SIZE="-0.7331456223468787" ORDER="132" O_E="0.0" SE="1.5564403995153682" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.422506717243559" WEIGHT="3.9579245048627265" />
<DICH_DATA CI_END="1.330313682804877" CI_START="0.3855303737683743" EFFECT_SIZE="0.7161538461538461" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="52" LOG_CI_END="0.12395405799612855" LOG_CI_START="-0.4139414006471169" LOG_EFFECT_SIZE="-0.14499367132549415" ORDER="122" O_E="0.0" SE="0.315962455032505" STUDY_ID="STD-Haag_x002d_Weber-2009" TOTAL_1="164" TOTAL_2="451" VAR="0.09983227299016773" WEIGHT="96.04207549513727" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="19.169328819740763" CI_END="1.1562551464689426" CI_START="0.8893752997805955" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0140733541088989" ESTIMABLE="YES" EVENTS_1="581" EVENTS_2="577" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.06305367878759832" LOG_CI_START="-0.050914936184529885" LOG_EFFECT_SIZE="0.006069371301534234" METHOD="MH" NO="4" P_CHI2="0.9363915961350198" P_Q="0.9548802736142934" P_Z="0.8346396385373578" Q="3.825391497913714" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5367" TOTAL_2="5665" WEIGHT="1100.0" Z="0.2087548254002608">
<NAME>All-cause mortality</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8074610326102014" CI_END="6.8568790881948365" CI_START="0.14229524756429832" DF="1" EFFECT_SIZE="0.9877759398634613" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.836126491336053" LOG_CI_START="-0.8468096044207536" LOG_EFFECT_SIZE="-0.005341556542350301" NO="1" P_CHI2="0.36887201891404375" P_Z="0.9900732485377246" STUDIES="2" TAU2="0.0" TOTAL_1="121" TOTAL_2="114" WEIGHT="99.99999999999999" Z="0.012441658920724463">
<NAME>Epoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="7.6476132814954" CI_START="0.01197973604482272" EFFECT_SIZE="0.30268199233716475" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8835259187608653" LOG_CI_START="-1.9215527508565446" LOG_EFFECT_SIZE="-0.5190134160478396" ORDER="22" O_E="0.0" SE="1.6477170958966214" STUDY_ID="STD-Roth-1994" TOTAL_1="43" TOTAL_2="40" VAR="2.714971628109996" WEIGHT="35.9952470917473" />
<DICH_DATA CI_END="21.64388753908306" CI_START="0.17050741030845068" EFFECT_SIZE="1.9210526315789473" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3353352686867803" LOG_CI_START="-0.7682567416794889" LOG_EFFECT_SIZE="0.2835392635036457" ORDER="21" O_E="0.0" SE="1.2356603598375357" STUDY_ID="STD-Nissenson-1995" TOTAL_1="78" TOTAL_2="74" VAR="1.5268565248738284" WEIGHT="64.00475290825268" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0209513578959457" CI_END="2.152874204702354" CI_START="0.17373980524023375" DF="2" EFFECT_SIZE="0.6115880517404751" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.3330186541617584" LOG_CI_START="-0.7601006696604857" LOG_EFFECT_SIZE="-0.21354100774936366" NO="2" P_CHI2="0.600210076376092" P_Z="0.44382004232218664" STUDIES="3" TAU2="0.0" TOTAL_1="179" TOTAL_2="132" WEIGHT="100.0" Z="0.765758458916788">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="3.7408952330572918" CI_START="0.005948326970254736" EFFECT_SIZE="0.14917127071823205" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5729755455833355" LOG_CI_START="-2.2256051670037302" LOG_EFFECT_SIZE="-0.8263148107101972" ORDER="24" O_E="0.0" SE="1.643900163771591" STUDY_ID="STD-Bennett-1991" TOTAL_1="90" TOTAL_2="41" VAR="2.7024077484482643" WEIGHT="15.256660071182678" />
<DICH_DATA CI_END="7.683717492245469" CI_START="0.14326130047049715" EFFECT_SIZE="1.0491803278688525" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8855713887489527" LOG_CI_START="-0.8438711108027124" LOG_EFFECT_SIZE="0.02085013897312016" ORDER="23" O_E="0.0" SE="1.0158830851150888" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="63" TOTAL_2="66" VAR="1.0320184426229508" WEIGHT="39.95056162660907" />
<DICH_DATA CI_END="4.006504958344622" CI_START="0.09321261149212676" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6027656845487566" LOG_CI_START="-1.0305253244389188" LOG_EFFECT_SIZE="-0.21387981994508098" ORDER="125" O_E="0.0" SE="0.9594032236002469" STUDY_ID="STD-Palazzuoli-2007" TOTAL_1="26" TOTAL_2="25" VAR="0.9204545454545454" WEIGHT="44.79277830220825" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.240627181420229" CI_START="0.9112276838763783" DF="0" EFFECT_SIZE="1.063246835443038" ESTIMABLE="YES" EVENTS_1="412" EVENTS_2="395" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="0.09364129207277908" LOG_CI_START="-0.04037309449072831" LOG_EFFECT_SIZE="0.026634098791025393" NO="3" P_CHI2="1.0" P_Z="0.4359509677397978" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="0.7790488130370077">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.240627181420229" CI_START="0.9112276838763783" EFFECT_SIZE="1.063246835443038" ESTIMABLE="YES" EVENTS_1="412" EVENTS_2="395" LOG_CI_END="0.09364129207277908" LOG_CI_START="-0.04037309449072831" LOG_EFFECT_SIZE="0.026634098791025393" ORDER="25" O_E="0.0" SE="0.07872071404931662" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.006196950820434275" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8659054549420393" CI_START="0.3887767926687349" DF="0" EFFECT_SIZE="1.0555555555555556" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="6" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="0.45726185909892547" LOG_CI_START="-0.41029966739987966" LOG_EFFECT_SIZE="0.0234810958495229" NO="4" P_CHI2="1.0" P_Z="0.9155067365620199" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="100.0" Z="0.10609530454474626">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="2.8659054549420393" CI_START="0.3887767926687349" EFFECT_SIZE="1.0555555555555556" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="6" LOG_CI_END="0.45726185909892547" LOG_CI_START="-0.41029966739987966" LOG_EFFECT_SIZE="0.0234810958495229" ORDER="26" O_E="0.0" SE="0.509609935164215" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="0.25970228601807543" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.38254518002970245" CI_END="1.3336092739948069" CI_START="0.3621326735602022" DF="2" EFFECT_SIZE="0.6949413585882047" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="23" I2="0.0" ID="CMP-001.04.05" LOG_CI_END="0.12502860693899928" LOG_CI_START="-0.441132289027965" LOG_EFFECT_SIZE="-0.1580518410444828" NO="5" P_CHI2="0.8259074810907175" P_Z="0.273821921622024" STUDIES="3" TAU2="0.0" TOTAL_1="243" TOTAL_2="225" WEIGHT="99.99999999999999" Z="1.0943034686574733">
<NAME>Epoetin beta versus control</NAME>
<DICH_DATA CI_END="4.0864899455378945" CI_START="0.03060679511429443" EFFECT_SIZE="0.35365853658536583" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6113504347113754" LOG_CI_START="-1.5141821436808967" LOG_EFFECT_SIZE="-0.4514158544847606" ORDER="29" O_E="0.0" SE="1.2485483581035732" STUDY_ID="STD-Kuriyama-1997" TOTAL_1="42" TOTAL_2="31" VAR="1.5588730025231288" WEIGHT="7.094866174015573" />
<DICH_DATA CI_END="3.49078364310554" CI_START="0.0991240926458109" EFFECT_SIZE="0.5882352941176471" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5429229323096811" LOG_CI_START="-1.003820775066229" LOG_EFFECT_SIZE="-0.2304489213782739" ORDER="27" O_E="0.0" SE="0.9085649102174436" STUDY_ID="STD-EPOCARES-Study-2010" TOTAL_1="20" TOTAL_2="13" VAR="0.8254901960784313" WEIGHT="13.398094111509725" />
<DICH_DATA CI_END="1.576884459835692" CI_START="0.3654714484424479" EFFECT_SIZE="0.759148369926813" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="18" LOG_CI_END="0.19779987323120515" LOG_CI_START="-0.43714654556859217" LOG_EFFECT_SIZE="-0.11967333616869354" ORDER="28" O_E="0.0" SE="0.37297066943846424" STUDY_ID="STD-Klinkmann-1992" TOTAL_1="181" TOTAL_2="181" VAR="0.13910712026137614" WEIGHT="79.50703971447469" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1590047052875898" CI_END="2.143864148310709" CI_START="0.5851121265743423" DF="5" EFFECT_SIZE="1.1200004066537521" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="20" I2="0.0" ID="CMP-001.04.06" LOG_CI_END="0.3311972616605123" LOG_CI_START="-0.2327609009497053" LOG_EFFECT_SIZE="0.04921818035540351" NO="6" P_CHI2="0.9487493263343729" P_Z="0.7322734572437328" STUDIES="6" TAU2="0.0" TOTAL_1="632" TOTAL_2="573" WEIGHT="100.0" Z="0.3421028979692612">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="77.64337794094007" CI_START="0.11591458587551284" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8901044214767324" LOG_CI_START="-0.9358619120374075" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="33" O_E="0.0" SE="1.6599866130651644" STUDY_ID="STD-Li-2008d" TOTAL_1="23" TOTAL_2="22" VAR="2.7555555555555555" WEIGHT="3.982536882263224" />
<DICH_DATA CI_END="8.487594298938681" CI_START="0.01353473309778433" EFFECT_SIZE="0.3389355742296919" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9287846124174202" LOG_CI_START="-1.8685503040089064" LOG_EFFECT_SIZE="-0.4698828457957431" ORDER="32" O_E="0.0" SE="1.6431683769399825" STUDY_ID="STD-Hori-2004" TOTAL_1="59" TOTAL_2="61" VAR="2.7000023149755767" WEIGHT="4.064478600724679" />
<DICH_DATA CI_END="6.087187662501893" CI_START="0.07796176617947671" EFFECT_SIZE="0.6888888888888889" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.7844166908663189" LOG_CI_START="-1.108118330748461" LOG_EFFECT_SIZE="-0.161850819941071" ORDER="34" O_E="0.0" SE="1.111684439895967" STUDY_ID="STD-Locatelli-2001" TOTAL_1="37" TOTAL_2="129" VAR="1.2358422939068099" WEIGHT="8.879856018224961" />
<DICH_DATA CI_END="7.23261179494518" CI_START="0.14001833836000055" EFFECT_SIZE="1.0063291139240507" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8592951552896105" LOG_CI_START="-0.8538150805575526" LOG_EFFECT_SIZE="0.002740037366028874" ORDER="30" O_E="0.0" SE="1.0062894325690552" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="1.0126184221001513" WEIGHT="10.837351357251876" />
<DICH_DATA CI_END="6.649147664345131" CI_START="0.17442285419956777" EFFECT_SIZE="1.0769230769230769" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.8227659778751628" LOG_CI_START="-0.7583966111323603" LOG_EFFECT_SIZE="0.032184683371401235" ORDER="31" O_E="0.0" SE="0.928782731664065" STUDY_ID="STD-Allon-2002" TOTAL_1="15" TOTAL_2="32" VAR="0.8626373626373626" WEIGHT="12.721570043724904" />
<DICH_DATA CI_END="2.9184282250295244" CI_START="0.5421465841746518" EFFECT_SIZE="1.2578616352201257" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.4651490168660094" LOG_CI_START="-0.26588327417895" LOG_EFFECT_SIZE="0.09963287134352969" ORDER="35" O_E="0.0" SE="0.429411986428011" STUDY_ID="STD-Nissenson-2002" TOTAL_1="338" TOTAL_2="168" VAR="0.1843946540880503" WEIGHT="59.51420709781035" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.016512642897187" CI_END="2.012435073134333" CI_START="0.5327025886996245" DF="6" EFFECT_SIZE="1.0353885130947598" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="56" I2="45.536303597232695" ID="CMP-001.04.07" LOG_CI_END="0.30372187769364756" LOG_CI_START="-0.27351519273041247" LOG_EFFECT_SIZE="0.015103342481617599" NO="7" P_CHI2="0.08786752261922937" P_Z="0.9183086423332714" STUDIES="7" TAU2="0.31714805684612485" TOTAL_1="1006" TOTAL_2="1214" WEIGHT="100.00000000000001" Z="0.10256447074127611">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="80.01587424694638" CI_START="0.1247952371198529" EFFECT_SIZE="3.16" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9031761546663477" LOG_CI_START="-0.9038019894295398" LOG_EFFECT_SIZE="0.49968708261840383" ORDER="39" O_E="0.0" SE="1.6488328566078296" STUDY_ID="STD-Milutinovic-2006" TOTAL_1="38" TOTAL_2="39" VAR="2.718649789029536" WEIGHT="3.787134971041387" />
<DICH_DATA CI_END="75.18171220903214" CI_START="0.26086456827998417" EFFECT_SIZE="4.428571428571429" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.8761122122326348" LOG_CI_START="-0.5835849045926029" LOG_EFFECT_SIZE="0.6462636538200158" ORDER="128" O_E="0.0" SE="1.44483826212024" STUDY_ID="STD-Spinowitz-2006" TOTAL_1="15" TOTAL_2="63" VAR="2.0875576036866357" WEIGHT="4.781032612773356" />
<DICH_DATA CI_END="15.347058330804572" CI_START="0.0581954424047584" EFFECT_SIZE="0.945054945054945" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1860251437787095" LOG_CI_START="-1.2351110259337614" LOG_EFFECT_SIZE="-0.02454294107752589" ORDER="126" O_E="0.0" SE="1.422187370906434" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.022616917965755" WEIGHT="4.9137312127053265" />
<DICH_DATA CI_END="1.3322785859438464" CI_START="0.17893180487542149" EFFECT_SIZE="0.48824892419728566" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" LOG_CI_END="0.12459504742260133" LOG_CI_START="-0.7473124573407987" LOG_EFFECT_SIZE="-0.3113587049590987" ORDER="36" O_E="0.0" SE="0.5121627843097775" STUDY_ID="STD-Haag_x002d_Weber-2009" TOTAL_1="164" TOTAL_2="314" VAR="0.26231071763194364" WEIGHT="19.84088720976468" />
<DICH_DATA CI_END="7.020146361634003" CI_START="0.9859466835048862" EFFECT_SIZE="2.6308724832214767" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.8463461667433934" LOG_CI_START="-0.006146569527026862" LOG_EFFECT_SIZE="0.42009979860818325" ORDER="127" O_E="0.0" SE="0.5007584531923471" STUDY_ID="STD-Haag_x002d_Weber-2012" TOTAL_1="163" TOTAL_2="174" VAR="0.25075902844359216" WEIGHT="20.244466894197416" />
<DICH_DATA CI_END="1.0503331697829494" CI_START="0.17097271573505268" EFFECT_SIZE="0.42376681614349776" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="0.021327080829105758" LOG_CI_START="-0.7670731899069012" LOG_EFFECT_SIZE="-0.37287305453889774" ORDER="38" O_E="0.0" SE="0.46311022167461163" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="0.2144710774195079" WEIGHT="21.62634007334875" />
<DICH_DATA CI_END="2.6409904765226133" CI_START="0.5896131391651691" EFFECT_SIZE="1.2478632478632479" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.4217668351330373" LOG_CI_START="-0.22943284705648634" LOG_EFFECT_SIZE="0.09616699403827546" ORDER="37" O_E="0.0" SE="0.3825179168085408" STUDY_ID="STD-Krivoshiev-2008" TOTAL_1="304" TOTAL_2="305" VAR="0.14631995667954573" WEIGHT="24.806407026169087" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0873217038178358" CI_START="0.38047310162995335" DF="0" EFFECT_SIZE="0.8911620294599017" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" I2="0.0" ID="CMP-001.04.08" LOG_CI_END="0.3195893888957226" LOG_CI_START="-0.41967604119724355" LOG_EFFECT_SIZE="-0.0500433261507605" NO="8" P_CHI2="1.0" P_Z="0.7907376081024731" STUDIES="1" TAU2="0.0" TOTAL_1="105" TOTAL_2="112" WEIGHT="100.0" Z="0.2653529109558055">
<NAME>Epoetin beta versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="2.0873217038178358" CI_START="0.38047310162995335" EFFECT_SIZE="0.8911620294599017" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.3195893888957226" LOG_CI_START="-0.41967604119724355" LOG_EFFECT_SIZE="-0.0500433261507605" ORDER="40" O_E="0.0" SE="0.43424817305950564" STUDY_ID="STD-Tolman-2005" TOTAL_1="105" TOTAL_2="112" VAR="0.18857147580551836" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0769720165987029" CI_END="5.350176222823115" CI_START="0.12121514279535632" DF="1" EFFECT_SIZE="0.8053088692109531" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-001.04.09" LOG_CI_END="0.7283680869444517" LOG_CI_START="-0.9164431225652235" LOG_EFFECT_SIZE="-0.09403751781038595" NO="9" P_CHI2="0.7814435755013536" P_Z="0.8226709282581017" STUDIES="2" TAU2="0.0" TOTAL_1="140" TOTAL_2="322" WEIGHT="100.0" Z="0.22411100682958504">
<NAME>Epoetin beta versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="12.180806856189891" CI_START="0.02706702724227364" EFFECT_SIZE="0.5741935483870968" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="1.0856760568998964" LOG_CI_START="-1.5675594399506536" LOG_EFFECT_SIZE="-0.24094169152537867" ORDER="41" O_E="0.0" SE="1.5585236645775404" STUDY_ID="STD-AMICUS-Study-2007" TOTAL_1="46" TOTAL_2="135" VAR="2.428996013048206" WEIGHT="38.43089655309409" />
<DICH_DATA CI_END="11.111263105239866" CI_START="0.08903364158816149" EFFECT_SIZE="0.9946236559139785" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="1.0457634314390671" LOG_CI_START="-1.050445863068872" LOG_EFFECT_SIZE="-0.0023412158149025085" ORDER="135" O_E="0.0" SE="1.2313237159973198" STUDY_ID="STD-Chen-2012e" TOTAL_1="94" TOTAL_2="187" VAR="1.5161580935774484" WEIGHT="61.56910344690592" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8238445599749786" CI_START="0.039767163357631086" DF="0" EFFECT_SIZE="0.3351063829787234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" I2="0.0" ID="CMP-001.04.10" LOG_CI_END="0.45084078706706365" LOG_CI_START="-1.40047538668726" LOG_EFFECT_SIZE="-0.4748172998100981" NO="10" P_CHI2="1.0" P_Z="0.31472084678395496" STUDIES="1" TAU2="0.0" TOTAL_1="95" TOTAL_2="195" WEIGHT="100.0" Z="1.0053656096755377">
<NAME>Epoetin beta versus biosimilar ESA</NAME>
<DICH_DATA CI_END="2.8238445599749786" CI_START="0.039767163357631086" EFFECT_SIZE="0.3351063829787234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.45084078706706365" LOG_CI_START="-1.40047538668726" LOG_EFFECT_SIZE="-0.4748172998100981" ORDER="42" O_E="0.0" SE="1.0874722846261473" STUDY_ID="STD-Gertz-2010" TOTAL_1="95" TOTAL_2="195" VAR="1.1825959698300126" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8778011006717003" CI_END="1.3953125278779295" CI_START="0.5856475473113145" DF="3" EFFECT_SIZE="0.903969778081358" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="46" I2="0.0" ID="CMP-001.04.11" LOG_CI_END="0.14467149358173398" LOG_CI_START="-0.23236367119715842" LOG_EFFECT_SIZE="-0.043846088807712194" NO="11" P_CHI2="0.8307814390066496" P_Z="0.6484939759077657" STUDIES="4" TAU2="0.0" TOTAL_1="716" TOTAL_2="713" WEIGHT="99.99999999999999" Z="0.45585538408045956">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="3.011968337439045" CI_START="0.42570938328031227" EFFECT_SIZE="1.1323529411764706" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.47885040214095326" LOG_CI_START="-0.37088677720846214" LOG_EFFECT_SIZE="0.05398181246624554" ORDER="43" O_E="0.0" SE="0.4991398254167222" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="162" VAR="0.2491405653170359" WEIGHT="19.687676879920726" />
<DICH_DATA CI_END="1.6301925812608011" CI_START="0.23180020546365063" EFFECT_SIZE="0.6147186147186147" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.21223891240303855" LOG_CI_START="-0.6348861834212142" LOG_EFFECT_SIZE="-0.21132363550908786" ORDER="44" O_E="0.0" SE="0.49760547462401966" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="154" TOTAL_2="153" VAR="0.2476112083757959" WEIGHT="19.80927672788682" />
<DICH_DATA CI_END="2.034315313407889" CI_START="0.39590283015536165" EFFECT_SIZE="0.8974358974358975" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.3084182682819024" LOG_CI_START="-0.40241139363434947" LOG_EFFECT_SIZE="-0.046996562676223555" ORDER="46" O_E="0.0" SE="0.41754486207318114" STUDY_ID="STD-STRIATA-Study-2008" TOTAL_1="156" TOTAL_2="153" VAR="0.17434371184371186" WEIGHT="28.134074328069886" />
<DICH_DATA CI_END="2.1539443277761396" CI_START="0.4683104120927083" EFFECT_SIZE="1.0043478260869565" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.33323447405384904" LOG_CI_START="-0.32946618630474617" LOG_EFFECT_SIZE="0.001884143874551419" ORDER="45" O_E="0.0" SE="0.38927364831581357" STUDY_ID="STD-PATRONUS-Study-2010" TOTAL_1="244" TOTAL_2="245" VAR="0.1515339732731037" WEIGHT="32.36897206412255" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.644125295113618" CI_END="1.1572002723362937" CI_START="0.8173014759610566" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9725129770666249" ESTIMABLE="YES" EVENTS_1="284" EVENTS_2="311" I2="0.0" I2_Q="30.87019707070344" ID="CMP-001.05" LOG_CI_END="0.06340852718311404" LOG_CI_START="-0.08761771679004146" LOG_EFFECT_SIZE="-0.012104594803463686" METHOD="MH" NO="5" P_CHI2="0.4756608568629701" P_Q="0.1924321166473112" P_Z="0.7533857685607988" Q="8.679324612188728" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3391" TOTAL_2="3709" WEIGHT="700.0" Z="0.31417810889154507">
<NAME>Cardiovascular mortality</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8044313287556892" CI_END="3.7477292661128825" CI_START="0.05501141370278295" DF="1" EFFECT_SIZE="0.4540571385895864" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.5737682101559674" LOG_CI_START="-1.2595471942534935" LOG_EFFECT_SIZE="-0.3428894920487631" NO="1" P_CHI2="0.3697718227940129" P_Z="0.46346465042376883" STUDIES="2" TAU2="0.0" TOTAL_1="153" TOTAL_2="107" WEIGHT="100.0" Z="0.7331537753693691">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="17.12967988682036" CI_START="0.06416439255985665" EFFECT_SIZE="1.0483870967741935" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2337492471052358" LOG_CI_START="-1.1927059128160324" LOG_EFFECT_SIZE="0.02052166714460168" ORDER="47" O_E="0.0" SE="1.4253117720845079" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="63" TOTAL_2="66" VAR="2.03151364764268" WEIGHT="57.086029157133645" />
<DICH_DATA CI_END="3.7408952330572918" CI_START="0.005948326970254736" EFFECT_SIZE="0.14917127071823205" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5729755455833355" LOG_CI_START="-2.2256051670037302" LOG_EFFECT_SIZE="-0.8263148107101972" ORDER="48" O_E="0.0" SE="1.643900163771591" STUDY_ID="STD-Bennett-1991" TOTAL_1="90" TOTAL_2="41" VAR="2.7024077484482643" WEIGHT="42.91397084286636" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2640034821526955" CI_START="0.871552054828924" DF="0" EFFECT_SIZE="1.049592698231603" ESTIMABLE="YES" EVENTS_1="259" EVENTS_2="250" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.10174827036853215" LOG_CI_START="-0.0597066688525291" LOG_EFFECT_SIZE="0.02102080075800154" NO="2" P_CHI2="1.0" P_Z="0.6097997885231514" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="0.5103592694115721">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.2640034821526955" CI_START="0.871552054828924" EFFECT_SIZE="1.049592698231603" ESTIMABLE="YES" EVENTS_1="259" EVENTS_2="250" LOG_CI_END="0.10174827036853215" LOG_CI_START="-0.0597066688525291" LOG_EFFECT_SIZE="0.02102080075800154" ORDER="49" O_E="0.0" SE="0.09483943051329008" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.008994517580085178" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8998821614778862" CI_END="1.025858900507573" CI_START="0.0764362787429219" DF="2" EFFECT_SIZE="0.28002292204407875" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="14" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="0.01108763080991933" LOG_CI_START="-1.1167004644840328" LOG_EFFECT_SIZE="-0.5528064168370569" NO="3" P_CHI2="0.38676388037361" P_Z="0.05467802710412449" STUDIES="3" TAU2="0.0" TOTAL_1="205" TOTAL_2="225" WEIGHT="100.0" Z="1.92142596990415">
<NAME>Epoetin beta versus no treatment</NAME>
<DICH_DATA CI_END="2.600732424681729" CI_START="0.05274445381095763" EFFECT_SIZE="0.37037037037037035" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4150956722797088" LOG_CI_START="-1.2778232005976835" LOG_EFFECT_SIZE="-0.43136376415898736" ORDER="50" O_E="0.0" SE="0.9944289260117531" STUDY_ID="STD-EPOCARES-Study-2010" TOTAL_1="20" TOTAL_2="13" VAR="0.9888888888888888" WEIGHT="44.379532062960116" />
<DICH_DATA CI_END="0.846910493195611" CI_START="0.01331034618105727" EFFECT_SIZE="0.10617283950617284" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07216248620447754" LOG_CI_START="-1.8758106490656867" LOG_EFFECT_SIZE="-0.973986567635082" ORDER="51" O_E="0.0" SE="1.0594718590670726" STUDY_ID="STD-Klinkmann-1992" TOTAL_1="181" TOTAL_2="181" VAR="1.1224806201550388" WEIGHT="39.09771390537485" />
<DICH_DATA CI_END="31.981179307934113" CI_START="0.05375074912426846" EFFECT_SIZE="1.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="1.5048944743409551" LOG_CI_START="-1.2696154786073541" LOG_EFFECT_SIZE="0.11763949786680052" ORDER="52" O_E="0.0" SE="1.6297608804076038" STUDY_ID="STD-Kuriyama-1997" TOTAL_1="4" TOTAL_2="31" VAR="2.656120527306968" WEIGHT="16.52275403166503" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.07132586430646394" CI_END="14.909560309861066" CI_START="0.31009554539127177" DF="1" EFFECT_SIZE="2.150206556549958" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.05.04" LOG_CI_END="1.173464836087687" LOG_CI_START="-0.5085044724788467" LOG_EFFECT_SIZE="0.33248018180442024" NO="4" P_CHI2="0.7894160214998182" P_Z="0.4384197178429923" STUDIES="2" TAU2="0.0" TOTAL_1="197" TOTAL_2="290" WEIGHT="100.0" Z="0.7748645336047947">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="75.12481444098778" CI_START="0.12282386955957514" EFFECT_SIZE="3.0376175548589344" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.875783412300585" LOG_CI_START="-0.9107172243134165" LOG_EFFECT_SIZE="0.48253309399358424" ORDER="53" O_E="0.0" SE="1.6368042673476728" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="2.679128209607552" WEIGHT="36.43492168948727" />
<DICH_DATA CI_END="20.01208091567887" CI_START="0.15547128884073544" EFFECT_SIZE="1.7638888888888888" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="1.3012922502158581" LOG_CI_START="-0.8083498011664815" LOG_EFFECT_SIZE="0.2464712245246884" ORDER="54" O_E="0.0" SE="1.2392141838785615" STUDY_ID="STD-Locatelli-2001" TOTAL_1="37" TOTAL_2="129" VAR="1.5356517935258092" WEIGHT="63.56507831051274" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.19119165512530953" CI_END="1.3543632265557237" CI_START="0.20483331491054016" DF="1" EFFECT_SIZE="0.5267055242622236" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="20" I2="0.0" ID="CMP-001.05.05" LOG_CI_END="0.1317351533696753" LOG_CI_START="-0.6885994065578134" LOG_EFFECT_SIZE="-0.278432126594069" NO="5" P_CHI2="0.6619266664372025" P_Z="0.1833621162758145" STUDIES="2" TAU2="0.0" TOTAL_1="256" TOTAL_2="401" WEIGHT="100.0" Z="1.330474094158631">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="15.347058330804572" CI_START="0.0581954424047584" EFFECT_SIZE="0.945054945054945" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1860251437787095" LOG_CI_START="-1.2351110259337614" LOG_EFFECT_SIZE="-0.02454294107752589" ORDER="129" O_E="0.0" SE="1.422187370906434" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.022616917965755" WEIGHT="11.480044862047789" />
<DICH_DATA CI_END="1.3322785859438464" CI_START="0.17893180487542149" EFFECT_SIZE="0.48824892419728566" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="19" LOG_CI_END="0.12459504742260133" LOG_CI_START="-0.7473124573407987" LOG_EFFECT_SIZE="-0.3113587049590987" ORDER="55" O_E="0.0" SE="0.5121627843097775" STUDY_ID="STD-Haag_x002d_Weber-2009" TOTAL_1="164" TOTAL_2="314" VAR="0.26231071763194364" WEIGHT="88.51995513795221" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8238445599749786" CI_START="0.039767163357631086" DF="0" EFFECT_SIZE="0.3351063829787234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" I2="0.0" ID="CMP-001.05.06" LOG_CI_END="0.45084078706706365" LOG_CI_START="-1.40047538668726" LOG_EFFECT_SIZE="-0.4748172998100981" NO="6" P_CHI2="1.0" P_Z="0.31472084678395496" STUDIES="1" TAU2="0.0" TOTAL_1="95" TOTAL_2="195" WEIGHT="100.0" Z="1.0053656096755377">
<NAME>Epoetin beta versus biosimilar ESA</NAME>
<DICH_DATA CI_END="2.8238445599749786" CI_START="0.039767163357631086" EFFECT_SIZE="0.3351063829787234" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="6" LOG_CI_END="0.45084078706706365" LOG_CI_START="-1.40047538668726" LOG_EFFECT_SIZE="-0.4748172998100981" ORDER="56" O_E="0.0" SE="1.0874722846261473" STUDY_ID="STD-Gertz-2010" TOTAL_1="95" TOTAL_2="195" VAR="1.1825959698300126" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.0164392845733634" CI_END="1.481760466211816" CI_START="0.3209557860181177" DF="2" EFFECT_SIZE="0.689622791911336" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="17" I2="0.0" ID="CMP-001.05.07" LOG_CI_END="0.17077800350139496" LOG_CI_START="-0.4935547906820228" LOG_EFFECT_SIZE="-0.16138839359031396" NO="7" P_CHI2="0.6015656983505895" P_Z="0.3409549757079533" STUDIES="3" TAU2="0.0" TOTAL_1="473" TOTAL_2="465" WEIGHT="100.0" Z="0.9522800672473132">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="2.2696038781903813" CI_START="0.21910785904193833" EFFECT_SIZE="0.705186533212011" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.35595006489003567" LOG_CI_START="-0.6593420447243962" LOG_EFFECT_SIZE="-0.15169598991718025" ORDER="57" O_E="0.0" SE="0.5963876109645144" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="162" VAR="0.35567818251196104" WEIGHT="42.81435058177223" />
<DICH_DATA CI_END="8.866235358402102" CI_START="0.24059107759778817" EFFECT_SIZE="1.4605263157894737" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9477392556683258" LOG_CI_START="-0.6187204826565936" LOG_EFFECT_SIZE="0.16450938650586608" ORDER="58" O_E="0.0" SE="0.9201462043928189" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="155" TOTAL_2="150" VAR="0.8466690374585112" WEIGHT="17.985930424556102" />
<DICH_DATA CI_END="1.6181904625777221" CI_START="0.14059154388226766" EFFECT_SIZE="0.4769736842105263" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.20902963716401401" LOG_CI_START="-0.8520407999115718" LOG_EFFECT_SIZE="-0.3215055813737788" ORDER="136" O_E="0.0" SE="0.623278027121572" STUDY_ID="STD-STRIATA-Study-2008" TOTAL_1="156" TOTAL_2="153" VAR="0.388475499092559" WEIGHT="39.19971899367167" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.390511381060765" CI_END="1.2394372211460065" CI_START="0.7680249250982171" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9756631995389617" ESTIMABLE="YES" EVENTS_1="147" EVENTS_2="146" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.09322453416931295" LOG_CI_START="-0.11462468536306768" LOG_EFFECT_SIZE="-0.010700075596877386" METHOD="MH" NO="6" P_CHI2="0.9075189982805271" P_Q="0.9342309042983019" P_Z="0.8400747626284989" Q="1.3067953083643102" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3271" TOTAL_2="3032" WEIGHT="600.0" Z="0.20179784989251223">
<NAME>Myocardial infarction</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="100.5098367576078" CI_START="0.11921468492289741" DF="0" EFFECT_SIZE="3.4615384615384617" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="2.002208567632053" LOG_CI_START="-0.9236702446950389" LOG_EFFECT_SIZE="0.5392691614685069" NO="1" P_CHI2="1.0" P_Z="0.4699978799327237" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="100.0" Z="0.7224825102108363">
<NAME>Epoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="100.5098367576078" CI_START="0.11921468492289741" EFFECT_SIZE="3.4615384615384617" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.002208567632053" LOG_CI_START="-0.9236702446950389" LOG_EFFECT_SIZE="0.5392691614685069" ORDER="59" O_E="0.0" SE="1.718675697694639" STUDY_ID="STD-Kleinman-1989" TOTAL_1="7" TOTAL_2="7" VAR="2.9538461538461536" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2458505539164404" CI_START="0.748735943102114" DF="0" EFFECT_SIZE="0.965822493759033" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="129" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.09546594962488864" LOG_CI_START="-0.1256713180456917" LOG_EFFECT_SIZE="-0.015102684210401512" NO="2" P_CHI2="1.0" P_Z="0.7889198496745042" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="0.2677135105636174">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.2458505539164404" CI_START="0.748735943102114" EFFECT_SIZE="0.965822493759033" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="129" LOG_CI_END="0.09546594962488864" LOG_CI_START="-0.1256713180456917" LOG_EFFECT_SIZE="-0.015102684210401512" ORDER="60" O_E="0.0" SE="0.12989712567682812" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.016873263259101677" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="25.262436019880305" CI_START="0.04026110968710929" DF="0" EFFECT_SIZE="1.0085106382978724" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="1.4024752266223957" LOG_CI_START="-1.3951142591456607" LOG_EFFECT_SIZE="0.0036804837383676015" NO="3" P_CHI2="1.0" P_Z="0.9958853098273058" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="99.99999999999999" Z="0.00515702222186855">
<NAME>Epoetin alfa versus no treatment</NAME>
<DICH_DATA CI_END="25.262436019880305" CI_START="0.04026110968710929" EFFECT_SIZE="1.0085106382978724" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.4024752266223957" LOG_CI_START="-1.3951142591456607" LOG_EFFECT_SIZE="0.0036804837383676015" ORDER="61" O_E="0.0" SE="1.6433179122314532" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="2.7004937606607418" WEIGHT="99.99999999999999" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.2608712519910261" CI_END="3.8131717053591454" CI_START="0.19665030799225175" DF="1" EFFECT_SIZE="0.8659453737310545" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="20.689761272539727" ID="CMP-001.06.04" LOG_CI_END="0.5812863617937396" LOG_CI_START="-0.70630536906491" LOG_EFFECT_SIZE="-0.06250950363558525" NO="4" P_CHI2="0.2614863335531443" P_Z="0.8490715920021951" STUDIES="2" TAU2="0.3615202920681839" TOTAL_1="495" TOTAL_2="330" WEIGHT="100.0" Z="0.19030314171949644">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="4.172737183318288" CI_START="0.00946695386670532" EFFECT_SIZE="0.1987538940809969" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6204210318650639" LOG_CI_START="-2.0237897392324835" LOG_EFFECT_SIZE="-0.7016843536837097" ORDER="62" O_E="0.0" SE="1.5532224959971137" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="2.412500122071504" WEIGHT="20.621578659715603" />
<DICH_DATA CI_END="4.108179116225497" CI_START="0.3921315745945936" EFFECT_SIZE="1.2692307692307692" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.6136493705368586" LOG_CI_START="-0.40656818672271977" LOG_EFFECT_SIZE="0.10354059190706949" ORDER="63" O_E="0.0" SE="0.5992808432926328" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="169" VAR="0.3591375291375291" WEIGHT="79.37842134028439" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.29084704946621076" CI_END="3.118208198801907" CI_START="0.48646978618465425" DF="1" EFFECT_SIZE="1.2316306571981714" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-001.06.05" LOG_CI_END="0.493905109112008" LOG_CI_START="-0.312944127853505" LOG_EFFECT_SIZE="0.09048049062925151" NO="5" P_CHI2="0.5896783079497547" P_Z="0.6602393383859212" STUDIES="2" TAU2="0.0" TOTAL_1="322" TOTAL_2="319" WEIGHT="100.00000000000001" Z="0.43958274932204405">
<NAME>Epoetin alfa versus biosimilar</NAME>
<DICH_DATA CI_END="71.37223702889148" CI_START="0.11531534913600613" EFFECT_SIZE="2.8688524590163933" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8535293091161535" LOG_CI_START="-0.9381128817650989" LOG_EFFECT_SIZE="0.4577082136755274" ORDER="133" O_E="0.0" SE="1.6398244417753602" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.689024199843872" WEIGHT="8.35343848148257" />
<DICH_DATA CI_END="3.008969287387767" CI_START="0.4321144398792568" EFFECT_SIZE="1.1402714932126696" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4784177549098746" LOG_CI_START="-0.3644012207170078" LOG_EFFECT_SIZE="0.05700826709643338" ORDER="64" O_E="0.0" SE="0.4950760383044456" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="0.24510028370322487" WEIGHT="91.64656151851744" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5865625188030048" CI_END="3.649549556553991" CI_START="0.06009687484099485" DF="1" EFFECT_SIZE="0.46832309672514916" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.06.06" LOG_CI_END="0.5622392652304556" LOG_CI_START="-1.2211481116012537" LOG_EFFECT_SIZE="-0.329454423185399" NO="6" P_CHI2="0.443751601236005" P_Z="0.46897446913190266" STUDIES="2" TAU2="0.0" TOTAL_1="317" TOTAL_2="311" WEIGHT="100.0" Z="0.724148676142316">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="4.121181019586909" CI_START="0.009350889921121286" EFFECT_SIZE="0.1963076923076923" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.61502169098203" LOG_CI_START="-2.029147055497454" LOG_EFFECT_SIZE="-0.7070626822577121" ORDER="65" O_E="0.0" SE="1.5531978105284383" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="161" VAR="2.4124234386303347" WEIGHT="45.48969670789075" />
<DICH_DATA CI_END="15.610389245503262" CI_START="0.05996769593680213" EFFECT_SIZE="0.9675324675324676" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1934137323427862" LOG_CI_START="-1.2220826371911642" LOG_EFFECT_SIZE="-0.014334452424189008" ORDER="66" O_E="0.0" SE="1.41887452436411" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="155" TOTAL_2="150" VAR="2.01320491588948" WEIGHT="54.51030329210924" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.40835632125722" CI_END="2.252816572172041" CI_START="1.2417752820175625" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="OR" EFFECT_SIZE="1.6725704571834261" ESTIMABLE="YES" EVENTS_1="125" EVENTS_2="72" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.3527258322313712" LOG_CI_START="0.0940430108085499" LOG_EFFECT_SIZE="0.22338442151996057" METHOD="MH" NO="7" P_CHI2="0.6763239455730945" P_Q="0.4606150322361642" P_Z="7.116874086851482E-4" Q="5.674557891021918" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3503" TOTAL_2="3173" WEIGHT="700.0" Z="3.3850366907109315">
<NAME>Stroke</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.212811142835353" CI_START="0.013027968420631378" DF="0" EFFECT_SIZE="0.3271028037383178" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.9144918361516163" LOG_CI_START="-1.8851233028214842" LOG_EFFECT_SIZE="-0.48531573333493394" NO="1" P_CHI2="1.0" P_Z="0.49680658050588056" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="53" WEIGHT="100.0" Z="0.6795229424398788">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="8.212811142835353" CI_START="0.013027968420631378" EFFECT_SIZE="0.32710280373831774" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9144918361516163" LOG_CI_START="-1.8851233028214842" LOG_EFFECT_SIZE="-0.48531573333493405" ORDER="67" O_E="0.0" SE="1.6445077909512413" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="53" TOTAL_2="53" VAR="2.704405874499332" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7596227229306036" CI_START="1.402730023157095" DF="0" EFFECT_SIZE="1.9674871399938785" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="53" I2="0.0" ID="CMP-001.07.02" LOG_CI_END="0.4408497123010626" LOG_CI_START="0.14697409245700097" LOG_EFFECT_SIZE="0.2939119023790318" NO="2" P_CHI2="1.0" P_Z="8.8397736626658E-5" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="3.92041193206994">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="2.7596227229306036" CI_START="1.402730023157095" EFFECT_SIZE="1.9674871399938785" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="53" LOG_CI_END="0.4408497123010626" LOG_CI_START="0.14697409245700097" LOG_EFFECT_SIZE="0.2939119023790318" ORDER="68" O_E="0.0" SE="0.17262399380418134" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.02979904323690604" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.815463821945869" CI_START="0.10011593215001952" DF="0" EFFECT_SIZE="0.991304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-001.07.03" LOG_CI_END="0.9919108266616764" LOG_CI_START="-0.9994968046959545" LOG_EFFECT_SIZE="-0.0037929890171390676" NO="3" P_CHI2="1.0" P_Z="0.994042891208802" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="100.0" Z="0.007466198030265034">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="9.815463821945869" CI_START="0.10011593215001952" EFFECT_SIZE="0.991304347826087" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.9919108266616764" LOG_CI_START="-0.9994968046959545" LOG_EFFECT_SIZE="-0.0037929890171390676" ORDER="69" O_E="0.0" SE="1.1697627002862294" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="1.3683447749809308" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.385289360125297" CI_START="0.007671154874151865" DF="0" EFFECT_SIZE="0.20325203252032525" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.07.04" LOG_CI_END="0.7312090435911929" LOG_CI_START="-2.1151392491259133" LOG_EFFECT_SIZE="-0.6919651027673602" NO="4" P_CHI2="1.0" P_Z="0.3406108318744533" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="13" WEIGHT="100.0" Z="0.9529590482322442">
<NAME>Epoetin beta versus control</NAME>
<DICH_DATA CI_END="5.385289360125296" CI_START="0.007671154874151865" EFFECT_SIZE="0.2032520325203252" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7312090435911929" LOG_CI_START="-2.1151392491259133" LOG_EFFECT_SIZE="-0.6919651027673603" ORDER="70" O_E="0.0" SE="1.6719590767933121" STUDY_ID="STD-EPOCARES-Study-2010" TOTAL_1="20" TOTAL_2="13" VAR="2.7954471544715447" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5612400950693595" CI_END="5.542196185129664" CI_START="0.37257914488468535" DF="2" EFFECT_SIZE="1.4369783281033768" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" I2="0.0" ID="CMP-001.07.05" LOG_CI_END="0.7436818950678685" LOG_CI_START="-0.42878145839035575" LOG_EFFECT_SIZE="0.15745021833875644" NO="5" P_CHI2="0.7553152861440545" P_Z="0.5986051009217485" STUDIES="3" TAU2="0.0" TOTAL_1="623" TOTAL_2="373" WEIGHT="100.00000000000001" Z="0.5264075101225346">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="7.540280497424652" CI_START="0.0589426937892088" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.8773875018668391" LOG_CI_START="-1.2295700199782018" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="72" O_E="0.0" SE="1.2376372779397167" STUDY_ID="STD-Hirakata-2010" TOTAL_1="128" TOTAL_2="43" VAR="1.5317460317460316" WEIGHT="30.96613442200421" />
<DICH_DATA CI_END="22.56107304527508" CI_START="0.18181345973581176" EFFECT_SIZE="2.0253164556962027" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3533597516304228" LOG_CI_START="-0.7403739688994561" LOG_EFFECT_SIZE="0.30649289136548336" ORDER="71" O_E="0.0" SE="1.2298695515883182" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="1.5125791139240508" WEIGHT="31.358527354226577" />
<DICH_DATA CI_END="18.30726089179207" CI_START="0.2251433832378392" EFFECT_SIZE="2.0302114803625377" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.2626233705951282" LOG_CI_START="-0.6475408120389151" LOG_EFFECT_SIZE="0.3075412792781065" ORDER="73" O_E="0.0" SE="1.122039896344437" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="169" VAR="1.2589735289886348" WEIGHT="37.675338223769224" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9969726779482542" CI_END="2.1470884011006173" CI_START="0.39006125785559187" DF="2" EFFECT_SIZE="0.9151480767943833" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" I2="0.0" ID="CMP-001.07.06" LOG_CI_END="0.33184992581483785" LOG_CI_START="-0.40886718307730724" LOG_EFFECT_SIZE="-0.0385086286312347" NO="6" P_CHI2="0.6074494975040017" P_Z="0.8385172799203213" STUDIES="3" TAU2="0.0" TOTAL_1="360" TOTAL_2="358" WEIGHT="100.0" Z="0.20379041959523012">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="80.01587424694638" CI_START="0.1247952371198529" EFFECT_SIZE="3.16" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9031761546663477" LOG_CI_START="-0.9038019894295398" LOG_EFFECT_SIZE="0.49968708261840383" ORDER="75" O_E="0.0" SE="1.6488328566078296" STUDY_ID="STD-Milutinovic-2006" TOTAL_1="38" TOTAL_2="39" VAR="2.718649789029536" WEIGHT="6.963485726911386" />
<DICH_DATA CI_END="7.754929277742541" CI_START="0.012529345882897568" EFFECT_SIZE="0.3117117117117117" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8895778415530778" LOG_CI_START="-1.9020716015408392" LOG_EFFECT_SIZE="-0.5062468799938808" ORDER="134" O_E="0.0" SE="1.6398287017609785" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="2.689038171119096" WEIGHT="7.040167449352049" />
<DICH_DATA CI_END="2.267668633202251" CI_START="0.36043489300061304" EFFECT_SIZE="0.9040723981900453" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.35557959286379887" LOG_CI_START="-0.44317317245409327" LOG_EFFECT_SIZE="-0.04379678979514719" ORDER="74" O_E="0.0" SE="0.46919132823768567" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="0.2201405024934437" WEIGHT="85.99634682373656" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.1920341237580079" CI_END="10.487396589471805" CI_START="0.16956761974763962" DF="1" EFFECT_SIZE="1.3335377298847781" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="16.1097841018679" ID="CMP-001.07.07" LOG_CI_END="1.0206676915155948" LOG_CI_START="-0.7706570760622956" LOG_EFFECT_SIZE="0.12500530772664958" NO="7" P_CHI2="0.27491969367800984" P_Z="0.7844326463229799" STUDIES="2" TAU2="0.38653345989646787" TOTAL_1="317" TOTAL_2="311" WEIGHT="100.0" Z="0.2735471595715838">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="8.141991973439128" CI_START="0.013312823171759955" EFFECT_SIZE="0.3292307692307692" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9107306699062137" LOG_CI_START="-1.8757298364935433" LOG_EFFECT_SIZE="-0.48249958329366477" ORDER="76" O_E="0.0" SE="1.6367806946611778" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="161" VAR="2.679051042415528" WEIGHT="36.11690888092028" />
<DICH_DATA CI_END="28.59125658160452" CI_START="0.3024785813050308" EFFECT_SIZE="2.9407894736842106" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4562332429573044" LOG_CI_START="-0.5193053725829763" LOG_EFFECT_SIZE="0.46846393518716395" ORDER="77" O_E="0.0" SE="1.1604411618422226" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="155" TOTAL_2="150" VAR="1.3466236900977275" WEIGHT="63.883091119079715" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="47.980262767065675" CI_END="1.3955339997567118" CI_START="1.0970525266960993" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2373253818310745" ESTIMABLE="YES" EVENTS_1="910" EVENTS_2="762" I2="52.06362226138636" I2_Q="68.78314535637192" ID="CMP-001.08" LOG_CI_END="0.14474042178262314" LOG_CI_START="0.040227422021512506" LOG_EFFECT_SIZE="0.09248392190206783" METHOD="MH" NO="8" P_CHI2="0.0016828290146080338" P_Q="6.92081101992148E-4" P_Z="5.228700591905847E-4" Q="28.83057919429773" RANDOM="YES" SCALE="200.0" SORT_BY="WEIGHT" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.12649496336457422" TOTALS="SUB" TOTAL_1="4897" TOTAL_2="5033" WEIGHT="1000.0" Z="3.4687580777777476">
<NAME>Hypertension</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.061039140132075134" CI_END="7.757475160823927" CI_START="2.16414813837401" DF="1" EFFECT_SIZE="4.09735590689651" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="17" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="0.8897203936620204" LOG_CI_START="0.3352869853977553" LOG_EFFECT_SIZE="0.6125036895298879" NO="1" P_CHI2="0.8048610147862754" P_Z="1.4877544889324565E-5" STUDIES="2" TAU2="0.0" TOTAL_1="145" TOTAL_2="106" WEIGHT="100.0" Z="4.330493631813343">
<NAME>Epoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="13.103774236838545" CI_START="0.962298778297196" EFFECT_SIZE="3.5510204081632653" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="3" LOG_CI_END="1.117396402079663" LOG_CI_START="-0.016690065571490918" LOG_EFFECT_SIZE="0.5503531682540861" ORDER="81" O_E="0.0" SE="0.6661680049168412" STUDY_ID="STD-Canadian-EPO-Study-1990" TOTAL_1="67" TOTAL_2="32" VAR="0.44377981077488465" WEIGHT="23.90047027480572" />
<DICH_DATA CI_END="8.908499652548263" CI_START="2.061777813901756" EFFECT_SIZE="4.285714285714286" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="14" LOG_CI_END="0.9498045673942312" LOG_CI_START="0.31424186201658005" LOG_EFFECT_SIZE="0.6320232147054056" ORDER="78" O_E="0.0" SE="0.3733326792249633" STUDY_ID="STD-Nissenson-1995" TOTAL_1="78" TOTAL_2="74" VAR="0.13937728937728938" WEIGHT="76.09952972519427" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.08440440296151874" CI_END="7.262598429372772" CI_START="1.1948816597005512" DF="1" EFFECT_SIZE="2.945835308537725" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="7" I2="0.0" ID="CMP-001.08.02" LOG_CI_END="0.8610920313940876" LOG_CI_START="0.07732489517202747" LOG_EFFECT_SIZE="0.46920846328305754" NO="2" P_CHI2="0.7714151305085695" P_Z="0.018940690024359923" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="87" WEIGHT="100.0" Z="2.346696223342601">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="11.665843973223403" CI_START="0.5092993069028954" EFFECT_SIZE="2.4375" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="1.0669161635888322" LOG_CI_START="-0.29302691484768356" LOG_EFFECT_SIZE="0.3869446243705744" ORDER="80" O_E="0.0" SE="0.7988372961004172" STUDY_ID="STD-Bennett-1991" TOTAL_1="90" TOTAL_2="41" VAR="0.6381410256410257" WEIGHT="33.214876093554956" />
<DICH_DATA CI_END="9.764568676331013" CI_START="1.0729758949620258" EFFECT_SIZE="3.236842105263158" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="5" LOG_CI_END="0.9896530642519831" LOG_CI_START="0.030589965393192493" LOG_EFFECT_SIZE="0.5101215148225878" ORDER="79" O_E="0.0" SE="0.5633584117085587" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="53" TOTAL_2="46" VAR="0.31737270004278995" WEIGHT="66.78512390644505" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3237229718178187" CI_START="0.9879885397326176" DF="0" EFFECT_SIZE="1.143600946981423" ESTIMABLE="YES" EVENTS_1="491" EVENTS_2="446" I2="0.0" ID="CMP-001.08.03" LOG_CI_END="0.12179710564795813" LOG_CI_START="-0.005248093023456457" LOG_EFFECT_SIZE="0.05827450631225081" NO="3" P_CHI2="1.0" P_Z="0.07217127020462555" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="1.7980362073228433">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.3237229718178187" CI_START="0.9879885397326176" EFFECT_SIZE="1.143600946981423" ESTIMABLE="YES" EVENTS_1="491" EVENTS_2="446" LOG_CI_END="0.12179710564795813" LOG_CI_START="-0.005248093023456457" LOG_EFFECT_SIZE="0.05827450631225081" ORDER="82" O_E="0.0" SE="0.07462697858346483" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.005569185932496917" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="95.19702714200517" CI_START="0.29662215675462983" DF="0" EFFECT_SIZE="5.313901345291479" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" I2="0.0" ID="CMP-001.08.04" LOG_CI_END="1.9786233862418072" LOG_CI_START="-0.5277964116458832" LOG_EFFECT_SIZE="0.725413487297962" NO="4" P_CHI2="1.0" P_Z="0.25657897866449086" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="100.0" Z="1.1345141066965974">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="95.19702714200517" CI_START="0.29662215675462983" EFFECT_SIZE="5.313901345291479" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="1.9786233862418072" LOG_CI_START="-0.5277964116458832" LOG_EFFECT_SIZE="0.725413487297962" ORDER="83" O_E="0.0" SE="1.472283396257326" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="2.167618398895007" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.01611637770223516" CI_END="6.6877491767093815" CI_START="1.335775445280182" DF="1" EFFECT_SIZE="2.98886786834767" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="10" I2="0.0" ID="CMP-001.08.05" LOG_CI_END="0.8252799765700526" LOG_CI_START="0.12573345583979828" LOG_EFFECT_SIZE="0.47550671620492546" NO="5" P_CHI2="0.8989797420559603" P_Z="0.007709946761606299" STUDIES="2" TAU2="0.0" TOTAL_1="193" TOTAL_2="189" WEIGHT="99.99999999999999" Z="2.6645148265355556">
<NAME>Epoetin beta versus no treatment</NAME>
<DICH_DATA CI_END="21.583871171877842" CI_START="0.5147876867235964" EFFECT_SIZE="3.3333333333333335" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="1.334129340152628" LOG_CI_START="-0.2883718495919527" LOG_EFFECT_SIZE="0.5228787452803376" ORDER="84" O_E="0.0" SE="0.9530652303663865" STUDY_ID="STD-Clyne-1992" TOTAL_1="12" TOTAL_2="8" VAR="0.9083333333333332" WEIGHT="18.589305039040536" />
<DICH_DATA CI_END="7.117790923381103" CI_START="1.1940825793033372" EFFECT_SIZE="2.9153439153439153" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="7" LOG_CI_END="0.852345226972765" LOG_CI_START="0.07703436238431674" LOG_EFFECT_SIZE="0.4646897946785409" ORDER="85" O_E="0.0" SE="0.4554214397099303" STUDY_ID="STD-Klinkmann-1992" TOTAL_1="181" TOTAL_2="181" VAR="0.2074086877474657" WEIGHT="81.41069496095945" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.310460163806297" CI_END="1.433745804222979" CI_START="0.6164315793490736" DF="4" EFFECT_SIZE="0.940109669390906" ESTIMABLE="YES" EVENTS_1="155" EVENTS_2="127" I2="45.28388213092537" ID="CMP-001.08.06" LOG_CI_END="0.1564721599726379" LOG_CI_START="-0.21011512078791314" LOG_EFFECT_SIZE="-0.026821480407637602" NO="6" P_CHI2="0.12036359204650571" P_Z="0.7742632928058526" STUDIES="5" TAU2="0.10247495808318127" TOTAL_1="866" TOTAL_2="702" WEIGHT="99.99999999999999" Z="0.2868028345225309">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="1.4076647355372218" CI_START="0.24904760987368482" EFFECT_SIZE="0.592094196804037" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="41" LOG_CI_END="0.1484992309111863" LOG_CI_START="-0.603717621864345" LOG_EFFECT_SIZE="-0.2276091954765794" ORDER="88" O_E="0.0" SE="0.4418559028538207" STUDY_ID="STD-Locatelli-2001" TOTAL_1="37" TOTAL_2="129" VAR="0.19523663888676504" WEIGHT="15.575221678460657" />
<DICH_DATA CI_END="3.0235344160055977" CI_START="0.5695588021359554" EFFECT_SIZE="1.312280701754386" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="9" LOG_CI_END="0.4805149164168251" LOG_CI_START="-0.24446143203288515" LOG_EFFECT_SIZE="0.11802674219196999" ORDER="87" O_E="0.0" SE="0.4258546957701623" STUDY_ID="STD-Hirakata-2010" TOTAL_1="128" TOTAL_2="43" VAR="0.18135222190949746" WEIGHT="16.337139097020444" />
<DICH_DATA CI_END="1.3809789502138603" CI_START="0.2831737004428911" EFFECT_SIZE="0.6253454401894987" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" LOG_CI_END="0.14018705882798824" LOG_CI_START="-0.5479470839021346" LOG_EFFECT_SIZE="-0.20388001253707325" ORDER="137" O_E="0.0" SE="0.40421340175861714" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="0.16338847416127322" WEIGHT="17.44099998976888" />
<DICH_DATA CI_END="4.073770929721493" CI_START="0.9517219686328297" EFFECT_SIZE="1.9690346083788706" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="12" LOG_CI_END="0.6099966047439468" LOG_CI_START="-0.02148990573750998" LOG_EFFECT_SIZE="0.2942533495032184" ORDER="86" O_E="0.0" SE="0.37093830216544865" STUDY_ID="STD-Coyne-2006a" TOTAL_1="206" TOTAL_2="200" VAR="0.1375952240133857" WEIGHT="19.314869004390857" />
<DICH_DATA CI_END="1.201434412960502" CI_START="0.5205803986116084" EFFECT_SIZE="0.7908496732026143" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="48" LOG_CI_END="0.07970006738560664" LOG_CI_START="-0.28351218838790415" LOG_EFFECT_SIZE="-0.10190606050114874" ORDER="89" O_E="0.0" SE="0.21335267697102295" STUDY_ID="STD-Nissenson-2002" TOTAL_1="335" TOTAL_2="169" VAR="0.04551936477070167" WEIGHT="31.331770230359147" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.297153937898433" CI_END="3.0926627402755758" CI_START="1.0183330947359073" DF="3" EFFECT_SIZE="1.7746438570257579" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="26" I2="0.0" ID="CMP-001.08.07" LOG_CI_END="0.4903325620906704" LOG_CI_START="0.007889858102880152" LOG_EFFECT_SIZE="0.24911121009677528" NO="7" P_CHI2="0.51306648283775" P_Z="0.042962908049771285" STUDIES="4" TAU2="0.0" TOTAL_1="551" TOTAL_2="913" WEIGHT="99.99999999999999" Z="2.0240704062848756">
<NAME>Epoetin alfa versus biosimilar ESA</NAME>
<DICH_DATA CI_END="156.07455309137936" CI_START="0.38868829741598776" EFFECT_SIZE="7.788732394366197" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1933321000330834" LOG_CI_START="-0.41039853486183736" LOG_EFFECT_SIZE="0.891466782585623" ORDER="92" O_E="0.0" SE="1.529444263611785" STUDY_ID="STD-Milutinovic-2006" TOTAL_1="38" TOTAL_2="39" VAR="2.3391997554949953" WEIGHT="3.4332021829801116" />
<DICH_DATA CI_END="3.4373294854601006" CI_START="0.1523035050776116" EFFECT_SIZE="0.7235449735449735" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.5362211634607169" LOG_CI_START="-0.8172901017962685" LOG_EFFECT_SIZE="-0.1405344691677758" ORDER="91" O_E="0.0" SE="0.7950592172007722" STUDY_ID="STD-Martin-2007" TOTAL_1="191" TOTAL_2="555" VAR="0.6321191588559048" WEIGHT="12.704797180214344" />
<DICH_DATA CI_END="4.412868930792772" CI_START="0.7463518322715386" EFFECT_SIZE="1.8148148148148149" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" LOG_CI_END="0.6447210284037336" LOG_CI_START="-0.12705639666468085" LOG_EFFECT_SIZE="0.2588323158695264" ORDER="90" O_E="0.0" SE="0.4533458798450547" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="0.20552248677248677" WEIGHT="39.07575191945887" />
<DICH_DATA CI_END="4.595895191766386" CI_START="0.8739222887593281" EFFECT_SIZE="2.004109589041096" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="0.6623701161527746" LOG_CI_START="-0.05852718414306464" LOG_EFFECT_SIZE="0.301921466004855" ORDER="130" O_E="0.0" SE="0.4234586426929644" STUDY_ID="STD-Goh-2007" TOTAL_1="92" TOTAL_2="87" VAR="0.17931722207136772" WEIGHT="44.78624871734667" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.685120519033663" CI_START="0.37940318370773674" DF="0" EFFECT_SIZE="1.1824324324324325" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-001.08.08" LOG_CI_END="0.5664516956944985" LOG_CI_START="-0.4208990291118243" LOG_EFFECT_SIZE="0.07277633329133706" NO="8" P_CHI2="1.0" P_Z="0.7726328227551219" STUDIES="1" TAU2="0.0" TOTAL_1="81" TOTAL_2="81" WEIGHT="100.0" Z="0.2889327745333531">
<NAME>Epoetin beta versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="3.685120519033663" CI_START="0.37940318370773674" EFFECT_SIZE="1.1824324324324325" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5664516956944985" LOG_CI_START="-0.4208990291118243" LOG_EFFECT_SIZE="0.07277633329133706" ORDER="93" O_E="0.0" SE="0.5799747032161457" STUDY_ID="STD-Tolman-2005" TOTAL_1="81" TOTAL_2="81" VAR="0.33637065637065633" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.092138756048576" CI_START="0.618437278666863" DF="0" EFFECT_SIZE="1.3828571428571428" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="25" I2="0.0" ID="CMP-001.08.09" LOG_CI_END="0.4902589741318426" LOG_CI_START="-0.20870433954356893" LOG_EFFECT_SIZE="0.1407773172941368" NO="9" P_CHI2="1.0" P_Z="0.4298153169475667" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="135" WEIGHT="100.0" Z="0.7895077362094812">
<NAME>Epoetin beta versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="3.092138756048576" CI_START="0.618437278666863" EFFECT_SIZE="1.3828571428571428" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="25" LOG_CI_END="0.4902589741318426" LOG_CI_START="-0.20870433954356893" LOG_EFFECT_SIZE="0.1407773172941368" ORDER="94" O_E="0.0" SE="0.4105745103771404" STUDY_ID="STD-AMICUS-Study-2007" TOTAL_1="46" TOTAL_2="135" VAR="0.16857142857142857" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.298026779520511" CI_END="1.4175556513806535" CI_START="0.6182579654007638" DF="4" EFFECT_SIZE="0.936170429390374" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="98" I2="36.48804395359315" ID="CMP-001.08.10" LOG_CI_END="0.15154011773291495" LOG_CI_START="-0.20883027964549497" LOG_EFFECT_SIZE="-0.028645080956290044" NO="10" P_CHI2="0.17796978275607922" P_Z="0.7553545780753015" STUDIES="5" TAU2="0.07912133557410528" TOTAL_1="742" TOTAL_2="755" WEIGHT="100.0" Z="0.3115867863564213">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="1.8030754655114438" CI_START="0.07087757408085563" EFFECT_SIZE="0.357487922705314" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.25601390396550866" LOG_CI_START="-1.1494911554173917" LOG_EFFECT_SIZE="-0.4467386257259416" ORDER="98" O_E="0.0" SE="0.8256006292437665" STUDY_ID="STD-TIVOLI-Study-2013" TOTAL_1="25" TOTAL_2="46" VAR="0.6816163990077033" WEIGHT="5.890314212980574" />
<DICH_DATA CI_END="2.034315313407889" CI_START="0.39590283015536165" EFFECT_SIZE="0.8974358974358975" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.3084182682819024" LOG_CI_START="-0.40241139363434947" LOG_EFFECT_SIZE="-0.046996562676223555" ORDER="97" O_E="0.0" SE="0.41754486207318114" STUDY_ID="STD-STRIATA-Study-2008" TOTAL_1="156" TOTAL_2="153" VAR="0.17434371184371186" WEIGHT="17.678904196093438" />
<DICH_DATA CI_END="1.9397948042361035" CI_START="0.44084720942342287" EFFECT_SIZE="0.9247448979591837" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.2877557917337235" LOG_CI_START="-0.355711903960613" LOG_EFFECT_SIZE="-0.03397805611344474" ORDER="138" O_E="0.0" SE="0.37797610966731743" STUDY_ID="STD-ARCTOS-Study-2008" TOTAL_1="162" TOTAL_2="161" VAR="0.14286593947923998" WEIGHT="20.18577096043481" />
<DICH_DATA CI_END="2.9160682897352808" CI_START="0.9293094427901745" EFFECT_SIZE="1.646186440677966" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="24" LOG_CI_END="0.4647976902590818" LOG_CI_START="-0.03183964992542882" LOG_EFFECT_SIZE="0.21647902016682646" ORDER="95" O_E="0.0" SE="0.2917272320188639" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="155" TOTAL_2="150" VAR="0.08510477790138807" WEIGHT="27.285455373250038" />
<DICH_DATA CI_END="1.1869150744385335" CI_START="0.40392583718412195" EFFECT_SIZE="0.6924057084607543" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="36" LOG_CI_END="0.07441964564187645" LOG_CI_START="-0.3936983662219168" LOG_EFFECT_SIZE="-0.15963936029002013" ORDER="96" O_E="0.0" SE="0.2749748373903225" STUDY_ID="STD-PATRONUS-Study-2010" TOTAL_1="244" TOTAL_2="245" VAR="0.0756111611978343" WEIGHT="28.959555257241142" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.719741492070217" CI_END="1.590454231453328" CI_START="0.880610930485475" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1834573843847003" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="99" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.20152117591853935" LOG_CI_START="-0.055215928210963765" LOG_EFFECT_SIZE="0.07315262385378778" METHOD="MH" NO="9" P_CHI2="0.7516117211252118" P_Q="0.6469855682759005" P_Z="0.2640315319140416" Q="5.106358217333051" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3515" TOTAL_2="3679" WEIGHT="800.0" Z="1.1169130275435988">
<NAME>Vascular access thrombosis</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="51.500647921805" CI_START="0.7960718849235309" DF="0" EFFECT_SIZE="6.402985074626867" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="1" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="1.7118126928682698" LOG_CI_START="-0.09904771390047387" LOG_EFFECT_SIZE="0.8063824894838979" NO="1" P_CHI2="1.0" P_Z="0.08088784297096255" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="40" WEIGHT="100.0" Z="1.745557671087813">
<NAME>Epoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="51.500647921805" CI_START="0.7960718849235309" EFFECT_SIZE="6.402985074626866" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="1" LOG_CI_END="1.7118126928682698" LOG_CI_START="-0.09904771390047387" LOG_EFFECT_SIZE="0.8063824894838978" ORDER="99" O_E="0.0" SE="1.0637083668395415" STUDY_ID="STD-Canadian-EPO-Study-1990" TOTAL_1="78" TOTAL_2="40" VAR="1.1314754896844448" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.340855740893484" CI_START="0.27558830191711614" DF="0" EFFECT_SIZE="1.09375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.6375753532252587" LOG_CI_START="-0.5597392211645194" LOG_EFFECT_SIZE="0.03891806603036966" NO="2" P_CHI2="1.0" P_Z="0.8986118263955996" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="46" WEIGHT="100.0" Z="0.1274151495338675">
<NAME>Epoetin beta versus placebo</NAME>
<DICH_DATA CI_END="4.340855740893484" CI_START="0.27558830191711614" EFFECT_SIZE="1.09375" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6375753532252587" LOG_CI_START="-0.5597392211645194" LOG_EFFECT_SIZE="0.03891806603036966" ORDER="100" O_E="0.0" SE="0.7033085077992851" STUDY_ID="STD-Bahlmann-1991" TOTAL_1="53" TOTAL_2="46" VAR="0.49464285714285716" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.009516855710673" CI_START="0.3002633074910837" DF="0" EFFECT_SIZE="1.343293492695883" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-001.09.03" LOG_CI_END="0.7788395576378029" LOG_CI_START="-0.5224977358255571" LOG_EFFECT_SIZE="0.1281709109061229" NO="3" P_CHI2="1.0" P_Z="0.699437174031917" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="0.3860803352113659">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="6.009516855710673" CI_START="0.3002633074910837" EFFECT_SIZE="1.343293492695883" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7788395576378029" LOG_CI_START="-0.5224977358255571" LOG_EFFECT_SIZE="0.1281709109061229" ORDER="101" O_E="0.0" SE="0.7644119679038711" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.584325656674669" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.7276031158638827" CI_START="0.7230197715394273" DF="0" EFFECT_SIZE="1.4043186895011168" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" I2="0.0" ID="CMP-001.09.04" LOG_CI_END="0.4357811778870251" LOG_CI_START="-0.1408498264218366" LOG_EFFECT_SIZE="0.1474656757325942" NO="4" P_CHI2="1.0" P_Z="0.31611704405481866" STUDIES="1" TAU2="0.0" TOTAL_1="181" TOTAL_2="181" WEIGHT="100.0" Z="1.0024692090158052">
<NAME>Epoetin beta versus control</NAME>
<DICH_DATA CI_END="2.7276031158638827" CI_START="0.7230197715394273" EFFECT_SIZE="1.4043186895011168" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="17" LOG_CI_END="0.4357811778870251" LOG_CI_START="-0.1408498264218366" LOG_EFFECT_SIZE="0.1474656757325942" ORDER="102" O_E="0.0" SE="0.33871590630053133" STUDY_ID="STD-Klinkmann-1992" TOTAL_1="181" TOTAL_2="181" VAR="0.11472846518099031" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.16356039364598865" CI_END="1.8222908330986733" CI_START="0.7268867222772024" DF="2" EFFECT_SIZE="1.150912251523498" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="31" I2="0.0" ID="CMP-001.09.05" LOG_CI_END="0.2606176904911033" LOG_CI_START="-0.13853326413830452" LOG_EFFECT_SIZE="0.06104221317639942" NO="5" P_CHI2="0.9214745079330963" P_Z="0.5488560790432342" STUDIES="3" TAU2="0.0" TOTAL_1="672" TOTAL_2="412" WEIGHT="100.0" Z="0.5994751508157588">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="5.289155517637198" CI_START="0.4085529330333114" EFFECT_SIZE="1.47" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7233863368164347" LOG_CI_START="-0.38875166732008254" LOG_EFFECT_SIZE="0.1673173347481761" ORDER="103" O_E="0.0" SE="0.653275368801697" STUDY_ID="STD-Coyne-2006a" TOTAL_1="206" TOTAL_2="200" VAR="0.42676870748299317" WEIGHT="12.881219506534876" />
<DICH_DATA CI_END="25.592874473440084" CI_START="0.04093375512917088" EFFECT_SIZE="1.0235294117647058" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.4081190665767251" LOG_CI_START="-1.3879184127680737" LOG_EFFECT_SIZE="0.010100326904325756" ORDER="104" O_E="0.0" SE="1.642406255975876" STUDY_ID="STD-Hirakata-2010" TOTAL_1="128" TOTAL_2="43" VAR="2.697498309668695" WEIGHT="2.037925799584202" />
<DICH_DATA CI_END="1.8303725907569495" CI_START="0.6757799049996397" EFFECT_SIZE="1.1121731050046462" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="27" LOG_CI_END="0.26253950374091506" LOG_CI_START="-0.1701947265556835" LOG_EFFECT_SIZE="0.046172388592615785" ORDER="105" O_E="0.0" SE="0.2541902289452088" STUDY_ID="STD-Nissenson-2002" TOTAL_1="338" TOTAL_2="169" VAR="0.06461267249121769" WEIGHT="85.08085469388092" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6053652696447893" CI_END="9.99834247533234" CI_START="0.30135637609097204" DF="1" EFFECT_SIZE="1.7358180363398095" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" I2="37.708880408178715" ID="CMP-001.09.06" LOG_CI_END="0.9999280086517851" LOG_CI_START="-0.5209196153066361" LOG_EFFECT_SIZE="0.2395041966725744" NO="6" P_CHI2="0.2051445810525725" P_Z="0.537028214848486" STUDIES="2" TAU2="0.7923786738390816" TOTAL_1="229" TOTAL_2="594" WEIGHT="100.0" Z="0.6173131249041913">
<NAME>Epoetin alfa versus biosimilar</NAME>
<DICH_DATA CI_END="2.9231787670619704" CI_START="0.36914518128024426" EFFECT_SIZE="1.0387864823348694" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="0.46585537545820566" LOG_CI_START="-0.43280279636533786" LOG_EFFECT_SIZE="0.016526289546433877" ORDER="106" O_E="0.0" SE="0.5278762585588433" STUDY_ID="STD-Martin-2007" TOTAL_1="191" TOTAL_2="555" VAR="0.2786533443500828" WEIGHT="74.51507743668309" />
<DICH_DATA CI_END="156.07455309137936" CI_START="0.38868829741598776" EFFECT_SIZE="7.788732394366197" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1933321000330834" LOG_CI_START="-0.41039853486183736" LOG_EFFECT_SIZE="0.891466782585623" ORDER="107" O_E="0.0" SE="1.529444263611785" STUDY_ID="STD-Milutinovic-2006" TOTAL_1="38" TOTAL_2="39" VAR="2.3391997554949953" WEIGHT="25.48492256331691" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.244505023938503" CI_START="0.48567666955930383" DF="0" EFFECT_SIZE="1.7414965986394557" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-001.09.07" LOG_CI_END="0.7954980193487988" LOG_CI_START="-0.31365275822145205" LOG_EFFECT_SIZE="0.24092263056367344" NO="7" P_CHI2="1.0" P_Z="0.3945129631274331" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="135" WEIGHT="100.0" Z="0.8514616560966904">
<NAME>Epoetin beta versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="6.244505023938503" CI_START="0.48567666955930383" EFFECT_SIZE="1.7414965986394557" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.7954980193487988" LOG_CI_START="-0.31365275822145205" LOG_EFFECT_SIZE="0.24092263056367344" ORDER="108" O_E="0.0" SE="0.6515206571296621" STUDY_ID="STD-AMICUS-Study-2007" TOTAL_1="46" TOTAL_2="135" VAR="0.4244791666666667" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.467752636745777" CI_START="0.39260662481898684" DF="0" EFFECT_SIZE="0.7591109331197436" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" I2="0.0" ID="CMP-001.09.08" LOG_CI_END="0.16665286923918343" LOG_CI_START="-0.40604237641697216" LOG_EFFECT_SIZE="-0.11969475358889438" NO="8" P_CHI2="1.0" P_Z="0.41262962514954304" STUDIES="1" TAU2="0.0" TOTAL_1="244" TOTAL_2="245" WEIGHT="100.00000000000001" Z="0.8192748515097014">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="1.467752636745777" CI_START="0.39260662481898684" EFFECT_SIZE="0.7591109331197436" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="22" LOG_CI_END="0.16665286923918343" LOG_CI_START="-0.40604237641697216" LOG_EFFECT_SIZE="-0.11969475358889438" ORDER="109" O_E="0.0" SE="0.3364040221856123" STUDY_ID="STD-PATRONUS-Study-2010" TOTAL_1="244" TOTAL_2="245" VAR="0.11316766614265793" WEIGHT="100.00000000000001" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.901534023358094" CI_END="1.222428551694088" CI_START="0.8844760687056035" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0398119059117719" ESTIMABLE="YES" EVENTS_1="404" EVENTS_2="382" I2="53.49390243720582" I2_Q="18.601154842865053" ID="CMP-001.10" LOG_CI_END="0.08722348496392951" LOG_CI_START="-0.05331391331356265" LOG_EFFECT_SIZE="0.01695478582518342" METHOD="MH" NO="10" P_CHI2="0.044626608748122965" P_Q="0.2962282007495971" P_Z="0.6362774012101424" Q="4.914074631253394" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.19404245588852323" TOTALS="SUB" TOTAL_1="2525" TOTAL_2="2433" WEIGHT="500.0" Z="0.472909986811273">
<NAME>End-stage kidney disease</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2251207757099478" CI_START="0.8789565454182513" DF="0" EFFECT_SIZE="1.0377031968429817" ESTIMABLE="YES" EVENTS_1="338" EVENTS_2="330" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.08817890473226755" LOG_CI_START="-0.05603259540582546" LOG_EFFECT_SIZE="0.016073154663221068" NO="1" P_CHI2="1.0" P_Z="0.6621858641949383" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="0.4368972547638583">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.2251207757099478" CI_START="0.8789565454182513" EFFECT_SIZE="1.0377031968429817" ESTIMABLE="YES" EVENTS_1="338" EVENTS_2="330" LOG_CI_END="0.08817890473226755" LOG_CI_START="-0.05603259540582546" LOG_EFFECT_SIZE="0.016073154663221068" ORDER="110" O_E="0.0" SE="0.08471054903955451" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.007175877118582769" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.115700830455295" CI_START="0.033611137306122876" DF="0" EFFECT_SIZE="0.26666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.32545425652564197" LOG_CI_START="-1.4735167919810797" LOG_EFFECT_SIZE="-0.5740312677277188" NO="2" P_CHI2="1.0" P_Z="0.21100580889165454" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="9" WEIGHT="100.0" Z="1.250804577072097">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="2.115700830455295" CI_START="0.033611137306122876" EFFECT_SIZE="0.26666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.32545425652564197" LOG_CI_START="-1.4735167919810797" LOG_EFFECT_SIZE="-0.5740312677277188" ORDER="111" O_E="0.0" SE="1.0567244989431572" STUDY_ID="STD-Brown-1995" TOTAL_1="8" TOTAL_2="9" VAR="1.1166666666666667" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3523331137418486" CI_END="1.9257338784674447" CI_START="0.0848796949828435" DF="1" EFFECT_SIZE="0.40429655479912874" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" I2="26.053722279043942" ID="CMP-001.10.03" LOG_CI_END="0.2845962707955094" LOG_CI_START="-1.0711961897512252" LOG_EFFECT_SIZE="-0.3932999594778579" NO="3" P_CHI2="0.24487081734721405" P_Z="0.25548543361780673" STUDIES="2" TAU2="0.5355594995892369" TOTAL_1="62" TOTAL_2="44" WEIGHT="100.0" Z="1.1371264823036575">
<NAME>Epoetin beta versus control</NAME>
<DICH_DATA CI_END="54.91899893293163" CI_START="0.07854493984355948" EFFECT_SIZE="2.076923076923077" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7397226122889313" LOG_CI_START="-1.10488178858463" LOG_EFFECT_SIZE="0.3174204118521506" ORDER="112" O_E="0.0" SE="1.6709347060920101" STUDY_ID="STD-EPOCARES-Study-2010" TOTAL_1="20" TOTAL_2="13" VAR="2.792022792022792" WEIGHT="19.06043590598398" />
<DICH_DATA CI_END="0.7299145783071259" CI_START="0.10360801420817674" EFFECT_SIZE="0.275" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" LOG_CI_END="-0.1367279622638721" LOG_CI_START="-0.9846066500756024" LOG_EFFECT_SIZE="-0.5606673061697374" ORDER="113" O_E="0.0" SE="0.49804813828780453" STUDY_ID="STD-Kuriyama-1997" TOTAL_1="42" TOTAL_2="31" VAR="0.24805194805194805" WEIGHT="80.93956409401602" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.9081017212614826" CI_END="12.744576229095273" CI_START="0.3695464927408939" DF="1" EFFECT_SIZE="2.1701874220746755" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="21" I2="47.59189256750521" ID="CMP-001.10.04" LOG_CI_END="1.1053253992854537" LOG_CI_START="-0.4323309151294694" LOG_EFFECT_SIZE="0.33649724207799214" NO="4" P_CHI2="0.16717451398780714" P_Z="0.3909873436283283" STUDIES="2" TAU2="1.0044777970961345" TOTAL_1="288" TOTAL_2="204" WEIGHT="100.0" Z="0.8578282015131169">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="2.4091992228365657" CI_START="0.694515378549603" EFFECT_SIZE="1.2935323383084578" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="21" LOG_CI_END="0.38187271440313963" LOG_CI_START="-0.1583181333024813" LOG_EFFECT_SIZE="0.11177729055032913" ORDER="114" O_E="0.0" SE="0.3173107779301034" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="0.1006861297906074" WEIGHT="73.81881260594845" />
<DICH_DATA CI_END="161.0666264933744" CI_START="0.541004799512329" EFFECT_SIZE="9.334763948497853" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="0" LOG_CI_END="2.2070055625715503" LOG_CI_START="-0.2667988820422763" LOG_EFFECT_SIZE="0.9701033402646371" ORDER="115" O_E="0.0" SE="1.453124976295656" STUDY_ID="STD-Hirakata-2010" TOTAL_1="128" TOTAL_2="43" VAR="2.111572196734251" WEIGHT="26.181187394051555" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.090222367217733" CI_START="0.6603073242452985" DF="0" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" I2="0.0" ID="CMP-001.10.05" LOG_CI_END="0.7067367549784457" LOG_CI_START="-0.1802538854292829" LOG_EFFECT_SIZE="0.2632414347745814" NO="5" P_CHI2="1.0" P_Z="0.24468439166791667" STUDIES="1" TAU2="0.0" TOTAL_1="155" TOTAL_2="150" WEIGHT="100.0" Z="1.1633577805503386">
<NAME>Darbepoetin alfa versus methoxy polyethylene glycol-epoetin beta</NAME>
<DICH_DATA CI_END="5.090222367217733" CI_START="0.6603073242452985" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.7067367549784457" LOG_CI_START="-0.1802538854292829" LOG_EFFECT_SIZE="0.2632414347745814" ORDER="116" O_E="0.0" SE="0.5210226928499817" STUDY_ID="STD-CORDATUS-Study-2011" TOTAL_1="155" TOTAL_2="150" VAR="0.2714646464646464" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.97287481328438" CI_END="1.2193343916748476" CI_START="0.9358666912773739" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0682389445706655" ESTIMABLE="YES" EVENTS_1="646" EVENTS_2="617" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.08612282337399982" LOG_CI_START="-0.028786009558742255" LOG_EFFECT_SIZE="0.02866840690762883" METHOD="MH" NO="11" P_CHI2="0.40968948357065116" P_Q="0.4097558259626819" P_Z="0.3280861670061209" Q="3.972387934878017" RANDOM="YES" SCALE="200.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="2540" TOTAL_2="2471" WEIGHT="500.0" Z="0.9779760806722326">
<NAME>Major cardiovascular events</NAME>
<GROUP_LABEL_1>Intervention</GROUP_LABEL_1>
<GROUP_LABEL_2>Comparator</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intervention</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours comparator</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2385747241936653" CI_START="0.9475033776388956" DF="0" EFFECT_SIZE="1.0833068515576099" ESTIMABLE="YES" EVENTS_1="632" EVENTS_2="602" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.0929222130421765" LOG_CI_START="-0.023419233193853486" LOG_EFFECT_SIZE="0.0347514899241615" NO="1" P_CHI2="1.0" P_Z="0.24164197441146007" STUDIES="1" TAU2="0.0" TOTAL_1="2012" TOTAL_2="2026" WEIGHT="100.0" Z="1.170892590114107">
<NAME>Darbepoetin alfa versus placebo</NAME>
<DICH_DATA CI_END="1.2385747241936653" CI_START="0.9475033776388956" EFFECT_SIZE="1.0833068515576099" ESTIMABLE="YES" EVENTS_1="632" EVENTS_2="602" LOG_CI_END="0.0929222130421765" LOG_CI_START="-0.023419233193853486" LOG_EFFECT_SIZE="0.0347514899241615" ORDER="117" O_E="0.0" SE="0.06833954141849086" STUDY_ID="STD-TREAT-Study-2005" TOTAL_1="2012" TOTAL_2="2026" VAR="0.004670292921289627" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="20.11349883232199" CI_START="0.2855155006364782" DF="0" EFFECT_SIZE="2.3963963963963963" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="1.303487624619564" LOG_CI_START="-0.5443703089307449" LOG_EFFECT_SIZE="0.37955865784440956" NO="2" P_CHI2="1.0" P_Z="0.42072071059969207" STUDIES="1" TAU2="0.0" TOTAL_1="118" TOTAL_2="39" WEIGHT="100.0" Z="0.8051715295732721">
<NAME>Epoetin alfa versus control</NAME>
<DICH_DATA CI_END="20.11349883232199" CI_START="0.2855155006364782" EFFECT_SIZE="2.3963963963963963" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.303487624619564" LOG_CI_START="-0.5443703089307449" LOG_EFFECT_SIZE="0.37955865784440956" ORDER="118" O_E="0.0" SE="1.0854408972117442" STUDY_ID="STD-Patel-2012" TOTAL_1="118" TOTAL_2="39" VAR="1.1781819413398362" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.983425487395677" CI_START="0.07493977607732313" DF="0" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="0.6975279690372501" LOG_CI_START="-1.125287608927412" LOG_EFFECT_SIZE="-0.21387981994508098" NO="3" P_CHI2="1.0" P_Z="0.6455562606655412" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="13" WEIGHT="100.0" Z="0.4599442194589331">
<NAME>Epoetin beta versus control</NAME>
<DICH_DATA CI_END="4.983425487395677" CI_START="0.07493977607732313" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.6975279690372501" LOG_CI_START="-1.125287608927412" LOG_EFFECT_SIZE="-0.21387981994508098" ORDER="119" O_E="0.0" SE="1.070730893579076" STUDY_ID="STD-EPOCARES-Study-2010" TOTAL_1="20" TOTAL_2="13" VAR="1.1464646464646464" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.172737183318288" CI_START="0.00946695386670532" DF="0" EFFECT_SIZE="0.19875389408099686" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-001.11.04" LOG_CI_END="0.6204210318650639" LOG_CI_START="-2.0237897392324835" LOG_EFFECT_SIZE="-0.7016843536837098" NO="4" P_CHI2="1.0" P_Z="0.2982392632642984" STUDIES="1" TAU2="0.0" TOTAL_1="160" TOTAL_2="161" WEIGHT="100.0" Z="1.0402166701442586">
<NAME>Epoetin alfa versus darbepoetin alfa</NAME>
<DICH_DATA CI_END="4.172737183318288" CI_START="0.00946695386670532" EFFECT_SIZE="0.1987538940809969" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6204210318650639" LOG_CI_START="-2.0237897392324835" LOG_EFFECT_SIZE="-0.7016843536837097" ORDER="120" O_E="0.0" SE="1.5532224959971137" STUDY_ID="STD-Akizawa-2011" TOTAL_1="160" TOTAL_2="161" VAR="2.412500122071504" WEIGHT="100.0" />
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4664434337126102" CI_START="0.16596465447127118" DF="0" EFFECT_SIZE="0.49333333333333335" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" I2="0.0" ID="CMP-001.11.05" LOG_CI_END="0.16626531525364616" LOG_CI_START="-0.7799843939030562" LOG_EFFECT_SIZE="-0.30685953932470506" NO="5" P_CHI2="1.0" P_Z="0.20365953889618216" STUDIES="1" TAU2="0.0" TOTAL_1="230" TOTAL_2="232" WEIGHT="100.0" Z="1.2711943571955693">
<NAME>Epoetin alfa versus biosimilar epoetin</NAME>
<DICH_DATA CI_END="1.4664434337126102" CI_START="0.16596465447127118" EFFECT_SIZE="0.49333333333333335" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="0.16626531525364616" LOG_CI_START="-0.7799843939030562" LOG_EFFECT_SIZE="-0.30685953932470506" ORDER="121" O_E="0.0" SE="0.5558317631702501" STUDY_ID="STD-Krivoshiev-2010" TOTAL_1="230" TOTAL_2="232" VAR="0.308948948948949" WEIGHT="100.0" />
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES />
<FEEDBACK />
<APPENDICES />
<EXTENSIONS />
</COCHRANE_REVIEW>
